<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Microbiol.</journal-id>
<journal-title>Frontiers in Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">1664-302X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fmicb.2022.896916</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Microbiology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>New Mutations in <italic>cls</italic> Lead to Daptomycin Resistance in a Clinical Vancomycin- and Daptomycin-Resistant <italic>Enterococcus faecium</italic> Strain</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Weiwei</given-names>
</name>
<xref rid="aff1" ref-type="aff"><sup>1</sup></xref>
<xref rid="aff2" ref-type="aff"><sup>2</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1746886/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hu</surname>
<given-names>Jiamin</given-names>
</name>
<xref rid="aff1" ref-type="aff"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Ling</given-names>
</name>
<xref rid="aff1" ref-type="aff"><sup>1</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/641437/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Mengge</given-names>
</name>
<xref rid="aff1" ref-type="aff"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cui</surname>
<given-names>Qingyu</given-names>
</name>
<xref rid="aff1" ref-type="aff"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ma</surname>
<given-names>Yanan</given-names>
</name>
<xref rid="aff1" ref-type="aff"><sup>1</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/659910/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Su</surname>
<given-names>Hainan</given-names>
</name>
<xref rid="aff1" ref-type="aff"><sup>1</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/506731/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Zhang</surname>
<given-names>Xuhua</given-names>
</name>
<xref rid="aff3" ref-type="aff"><sup>3</sup></xref>
<xref rid="c001" ref-type="corresp"><sup>&#x002A;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1155899/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Xu</surname>
<given-names>Hai</given-names>
</name>
<xref rid="aff1" ref-type="aff"><sup>1</sup></xref>
<xref rid="c002" ref-type="corresp"><sup>&#x002A;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/432465/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Wang</surname>
<given-names>Mingyu</given-names>
</name>
<xref rid="aff1" ref-type="aff"><sup>1</sup></xref>
<xref rid="c003" ref-type="corresp"><sup>&#x002A;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/434658/overview"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>State Key Laboratory of Microbial Technology, Microbial Technology Institute, Shandong University</institution>, <addr-line>Qingdao</addr-line>, <country>China</country>
</aff>
<aff id="aff2"><sup>2</sup><institution>Division of Science and Technology, Ludong University</institution>, <addr-line>Yantai</addr-line>, <country>China</country>
</aff>
<aff id="aff3"><sup>3</sup><institution>Laboratory Medicine Center, The Second Hospital of Shandong University</institution>, <addr-line>Jinan</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn id="fn0001" fn-type="edited-by">
<p>Edited by: Hidetada Hirakawa, Gunma University, Japan</p>
</fn>
<fn id="fn0002" fn-type="edited-by">
<p>Reviewed by: Milya Davlieva, Quantapore, United States; Xiaogang Xu, Fudan University, China</p>
</fn>
<corresp id="c001">&#x002A;Correspondence: Xuhua Zhang, <email>chh8105@126.com</email></corresp>
<corresp id="c002">Hai Xu, <email>haixu@sdu.edu.cn</email></corresp>
<corresp id="c003">Mingyu Wang, <email>wangmingyu@sdu.edu.cn</email></corresp>
<fn id="fn0003" fn-type="other">
<p>This article was submitted to Antimicrobials, Resistance and Chemotherapy, a section of the journal Frontiers in Microbiology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>21</day>
<month>06</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>13</volume>
<elocation-id>896916</elocation-id>
<history>
<date date-type="received">
<day>15</day>
<month>03</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>19</day>
<month>05</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2022 Li, Hu, Li, Zhang, Cui, Ma, Su, Zhang, Xu and Wang.</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Li, Hu, Li, Zhang, Cui, Ma, Su, Zhang, Xu and Wang</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Daptomycin (DAP), a last-resort antibiotic for treating Gram-positive bacterial infection, has been widely used in the treatment of vancomycin-resistant enterococci (VRE). Resistance to both daptomycin and vancomycin leads to difficulties in controlling infections of enterococci. A clinical multidrug-resistant <italic>Enterococcus faecium</italic> EF332 strain that shows resistance to both daptomycin and vancomycin was identified, for which resistance mechanisms were investigated in this work. Whole-genome sequencing and comparative genomic analysis were performed by third-generation PacBio sequencing, showing that <italic>E. faecium</italic> EF332 contains four plasmids, including a new multidrug-resistant pEF332-2 plasmid. Two vancomycin resistance-conferring gene clusters <italic>vanA</italic> and <italic>vanM</italic> were found on this plasmid, making it the second reported vancomycin-resistant plasmid containing both clusters. New mutations in chromosomal genes <italic>cls</italic> and <italic>gdpD</italic> that, respectively, encode cardiolipin synthase and glycerophosphoryl diester phosphodiesterase were identified. Their potential roles in leading to daptomycin resistance were further investigated. Through molecular cloning and phenotypic screening, two-dimensional thin-layer chromatography, fluorescence surface charge test, and analysis of cardiolipin distribution patterns, we found that mutations in <italic>cls</italic> decrease surface negative charges of the cell membrane (CM) and led to redistribution of lipids of CM. Both events contribute to the DAP resistance of <italic>E. faecium</italic> EF332. Mutation in <italic>gdpD</italic> leads to changes in CM phospholipid compositions, but cannot confer DAP resistance. Neither mutation could result in changes in cellular septa. Therefore, we conclude that the daptomycin resistance of <italic>E. faecium</italic> EF332 is conferred by new <italic>cls</italic> mutations. This work reports the genetic basis for vancomycin and daptomycin resistance of a multidrug-resistant <italic>E. faecium</italic> strain, with the finding of new mutations of <italic>cls</italic> that leads to daptomycin resistance.</p>
</abstract>
<kwd-group>
<kwd>vancomycin-resistant enterococci</kwd>
<kwd><italic>Enterococcus faecium</italic></kwd>
<kwd>daptomycin resistance</kwd>
<kwd>vancomycin resistance</kwd>
<kwd>membrane surface charge</kwd>
<kwd><italic>gdpD</italic></kwd>
<kwd><italic>cls</italic></kwd>
</kwd-group>
<contract-num rid="cn1">2021YFE0199800</contract-num>
<contract-num rid="cn2">2020CXGC011305</contract-num>
<contract-num rid="cn3">31770042</contract-num>
<contract-num rid="cn3">31770043</contract-num>
<contract-num rid="cn4">ZR2020MH308</contract-num>
<contract-sponsor id="cn1">National Key Research and Development Program of China<named-content content-type="fundref-id">10.13039/501100012166</named-content>
</contract-sponsor>
<contract-sponsor id="cn2">Key R&#x0026;D Program of Shandong Province</contract-sponsor>
<contract-sponsor id="cn3">National Natural Science Foundation of China<named-content content-type="fundref-id">10.13039/501100001809</named-content>
</contract-sponsor>
<contract-sponsor id="cn4">Shandong Provincial Natural Science Foundation<named-content content-type="fundref-id">10.13039/501100007129</named-content>
</contract-sponsor>
<counts>
<fig-count count="11"/>
<table-count count="4"/>
<equation-count count="0"/>
<ref-count count="66"/>
<page-count count="15"/>
<word-count count="8816"/>
</counts>
</article-meta>
</front>
<body>
<sec id="sec1" sec-type="intro">
<title>Introduction</title>
<p><italic>Enterococcus faecium</italic>, a Gram-positive coccus, is an important nosocomial pathogen that can cause fatal bacteremia and myocarditis (<xref ref-type="bibr" rid="ref2">Arias and Murray, 2012</xref>). The emergence of multidrug-resistant (MDR) <italic>E. faecium</italic>, particularly vancomycin-resistant enterococci (VRE), led to high morbidity and mortality in hospitalized patients (<xref ref-type="bibr" rid="ref61">Tran et al., 2013a</xref>, <xref ref-type="bibr" rid="ref60">2015</xref>; <xref ref-type="bibr" rid="ref25">Herc et al., 2017</xref>; <xref ref-type="bibr" rid="ref36">Lebreton et al., 2018</xref>). To make matters worse, the horizontal transfer of antibiotic resistance genes (ARGs) directly led to the rapid increase in VRE. In recent decades, VRE was gradually recognized as a major cause of MDR hospital infection in many countries (<xref ref-type="bibr" rid="ref63">Uttley et al., 1988</xref>; <xref ref-type="bibr" rid="ref10">Cattoir and Giard, 2014</xref>). A rapid increase of VRE undoubtedly brings more difficulties for the treatment of <italic>E. faecium</italic> infections (<xref ref-type="bibr" rid="ref16">Depardieu et al., 2007</xref>; <xref ref-type="bibr" rid="ref36">Lebreton et al., 2018</xref>). Initially, linezolid and quinupristin&#x2013;dalfopristin were used to treat VRE infections, but their use was hampered by their strong adverse drug effects (<xref ref-type="bibr" rid="ref9">Carver et al., 2003</xref>; <xref ref-type="bibr" rid="ref27">Hogan et al., 2010</xref>; <xref ref-type="bibr" rid="ref41">Matsumoto et al., 2010</xref>). By contrast, daptomycin (DAP) was generally considered to be a safer antimicrobial agent and gradually became the front-line drug for the patients who have VRE infections (<xref ref-type="bibr" rid="ref13">Chow et al., 2016</xref>; <xref ref-type="bibr" rid="ref21">Gonzalez-Ruiz et al., 2016</xref>; <xref ref-type="bibr" rid="ref25">Herc et al., 2017</xref>; <xref ref-type="bibr" rid="ref55">Suleyman et al., 2017</xref>).</p>
<p>Daptomycin is a cyclic lipopeptide antibiotic produced by <italic>Streptomyces roseosporus</italic> (<xref ref-type="bibr" rid="ref24">Heidary et al., 2018</xref>), which has a special mechanism that binds to Ca<sup>2+</sup> and inserts into the cell membrane (CM) causing leakage of intracellular ions and ATP, thus killing bacteria (<xref ref-type="bibr" rid="ref35">LaPlante and Rybak, 2004</xref>; <xref ref-type="bibr" rid="ref24">Heidary et al., 2018</xref>). Unfortunately, the widespread use of daptomycin resulted in the emergence of daptomycin non-susceptible VRE (DNVRE), which undoubtedly further reduced the option of treatment for VRE infections (<xref ref-type="bibr" rid="ref46">Munoz-Price et al., 2005</xref>; <xref ref-type="bibr" rid="ref39">Lellek et al., 2015</xref>; <xref ref-type="bibr" rid="ref13">Chow et al., 2016</xref>; <xref ref-type="bibr" rid="ref30">Hussain et al., 2016</xref>; <xref ref-type="bibr" rid="ref25">Herc et al., 2017</xref>). Multiple studies suggested that the mechanism of daptomycin resistance is mainly related to mutations in chromosomal genes, including <italic>mprF</italic>, <italic>gdpD</italic>, <italic>yycG</italic>, <italic>rpoB</italic>, <italic>rpoC</italic>, <italic>pgsA</italic>, <italic>cls</italic>, <italic>liaFSR</italic>, etc. (<xref ref-type="bibr" rid="ref18">Fischer et al., 2011</xref>; <xref ref-type="bibr" rid="ref61">Tran et al., 2013a</xref>,<xref ref-type="bibr" rid="ref62">b</xref>; <xref ref-type="bibr" rid="ref24">Heidary et al., 2018</xref>). With the increase of reports on DNVRE, a series of investigations were carried out to try to find the resistance mechanisms of daptomycin and effective applications of DAP (<xref ref-type="bibr" rid="ref46">Munoz-Price et al., 2005</xref>; <xref ref-type="bibr" rid="ref39">Lellek et al., 2015</xref>; <xref ref-type="bibr" rid="ref13">Chow et al., 2016</xref>; <xref ref-type="bibr" rid="ref30">Hussain et al., 2016</xref>; <xref ref-type="bibr" rid="ref55">Suleyman et al., 2017</xref>). However, the mechanism of DAP resistance has not been fully elucidated: One view is that DAP is diverted from effective targets at the septum by redistribution of anionic phospholipids; another view is that resistant bacteria achieve electrostatic repulsion to DAP by reducing the negative surface charge of CM (<xref ref-type="bibr" rid="ref24">Heidary et al., 2018</xref>). In summary, the reports on DAP resistance mainly focus on the interaction between CM and DAP&#x2013;Ca<sup>2+</sup> complex.</p>
<p>In view of this, in the present study, a clinical multidrug-resistant <italic>E. faecium</italic> from a hospital showing daptomycin resistance and high-level vancomycin resistance was identified. Whole-genome sequencing and subsequent mechanistic investigations were performed, hoping to find the answers to the following questions: (1) the genetic basis of the multidrug resistance; (2) the risk of multiple resistance transmission; and (3) the mechanism of daptomycin resistance.</p>
</sec>
<sec id="sec2" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="sec3">
<title>Strains</title>
<p><italic>Enterococcus faecium</italic> EF332 strain used in this study was isolated in the Laboratory Medicine Center of the Second Hospital of Shandong University. The laboratory maintains an opportunistic pathogen library isolated from patient samples and routinely screens them for possible new findings. The strain was identified by the analysis of 16S rDNA sequence.</p>
</sec>
<sec id="sec4">
<title>Antibiotic Susceptibility Tests</title>
<p>Antibiotic susceptibility tests were conducted according to CLSI/EUCAST guidelines (<xref ref-type="bibr" rid="ref17">EUCAST, 2017</xref>; <xref ref-type="bibr" rid="ref14">CLSI, 2018</xref>). The tested antibiotics include: penicillin (PEN), ampicillin (AMP), ciprofloxacin (CIP), gatifloxacin (GAT), chloramphenicol (CHL), tetracycline (TET), tigecycline (TGC), fosfomycin (FOF), erythromycin (ERY), linezolid (LZD), rifampicin (RIF), vancomycin (VAN), and daptomycin (DAP). K-B Disk diffusion assays were performed as previously documented (<xref ref-type="bibr" rid="ref64">Vading et al., 2011</xref>). Agar dilution method (for FOF) and broth microdilution method (for the rest antibiotics) were adopted to determine MICs of antibiotics. <italic>Staphylococcus aureus</italic> ATCC 25923 and <italic>Enterococcus faecalis</italic> ATCC 29212 were used as control strains for disk diffusion and dilution method, respectively, according to CLSI and EUCAST standards (<xref ref-type="bibr" rid="ref17">EUCAST, 2017</xref>; <xref ref-type="bibr" rid="ref14">CLSI, 2018</xref>).</p>
</sec>
<sec id="sec5">
<title>Extraction and Sequencing of Genomic DNA</title>
<p>The genomic DNA of <italic>E. faecium</italic> EF332 and constructed strains (29212-pDL278, EFDO-<italic>cls</italic>, EF332-<italic>cls</italic>) was extracted following previous reported protocol (<xref ref-type="bibr" rid="ref50">Qian and Zhao, 2014</xref>), and the purity and integrity of the DNA were confirmed by agarose gel electrophoresis. DNA samples of <italic>E. faecium</italic> EF332 were constructed into a 10-kb SMRTbell DNA library, and PacBio single-molecule sequencing was used to obtain at least 50&#x00D7; of sequencing data. In addition, a 350-bp small fragment library was constructed, and Illumina NovaSeq PE150 platform was used for paired-end sequencing to obtain at least 100&#x00D7; clean data for auxiliary assembly. DNA samples of constructed strains were used as templates for quantitative polymerase chain reaction (qPCR) to detect the relative copy number of plasmids.</p>
</sec>
<sec id="sec6">
<title>Conjugation and Transformation of Plasmid</title>
<p>To verify the transferability of plasmid pEF332-2, we conducted conjugation and transformation experiments. A chloramphenicol-resistant and vancomycin-sensitive <italic>E. faecalis</italic> 3&#x2013;147 strain was used as the recipient for conjugations, and vancomycin-sensitive <italic>E. faecalis</italic> ATCC 29212 was used as recipient for transformation. Transconjugants were identified on the plates containing 32&#x2009;&#x03BC;g/ml of vancomycin and 50&#x2009;&#x03BC;g/ml of chloramphenicol, and transformants were identified on the plates containing 32&#x2009;&#x03BC;g/ml of vancomycin.</p>
</sec>
<sec id="sec7">
<title>Acquisition, Cloning, and Transformation of Presumed DAP Resistance Genes</title>
<p>Genomic DNA of <italic>E. faecium</italic> EF332 strain was used as template to amplify the presumed DAP resistance genes <italic>cls</italic> and <italic>gdpD</italic> by PCR using Phanta super-fidelity DNA polymerase (Vazyme Biotech Co. Ltd. Nanjing, China). All the PCR products were analyzed by 1% agarose gel electrophoresis and purified by DNA clean-up kit (TIANGEN, Beijing, China).</p>
<p>All primer sequences are shown in <xref ref-type="supplementary-material" rid="SM1">Supplementary Table 1</xref>, in which the cleavage sites of BamHI and SalI were added to the 5&#x2032; ends for the next step of cloning. The shuttle plasmid pDL278 with spectinomycin resistance was used for molecular cloning (Genbank accession number AF216802.1). The <italic>cls</italic>, <italic>gdpD</italic> fragments and pDL278 vector, were digested by BamHI and SalI endonuclease, respectively, and then, the gene fragments were ligated to pDL278 vector by T4 DNA ligase to generate recombinant shuttle plasmids (pDL278-<italic>cls</italic>, pDL278-<italic>gdpD</italic>). These recombinant plasmids were transferred into <italic>Escherichia coli</italic> DH5&#x03B1; chemically competent cells, respectively, according to the manufacturer&#x2019;s protocols, and Luria-Bertani (LB) agar plates with 500&#x2009;mg/L spectinomycin were used to select for positive transformants. The plasmids of the positive clones were extracted and transformed into the electroporation competent cells of <italic>E. faecalis</italic> ATCC 29212, and tryptic soy broth (TSB) agar plates with 1,000&#x2009;mg/L spectinomycin were used to select for positive transformants. The successfully transferred gene fragments were validated by Sanger sequencing using primer M13 (as shown in <xref ref-type="supplementary-material" rid="SM1">Supplementary Table 1</xref>). Finally, we obtained the EF332-<italic>cls</italic> and EF332-<italic>gdpD</italic> strains for downstream analysis. A summary of constructed strains is shown in <xref rid="tab1" ref-type="table">Table 1</xref> for easier comparison.</p>
<table-wrap position="float" id="tab1">
<label>Table 1</label>
<caption><p>Constructed strains in this study.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Strain</th>
<th align="left" valign="top">Description</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">EF332-<italic>cls</italic></td>
<td align="left" valign="top"><italic>Enterococcus faecalis</italic> ATCC 29212 harboring plasmid pDL278 that carries <italic>cls</italic> gene originated from <italic>E. faecium</italic> EF332</td>
</tr>
<tr>
<td align="left" valign="top">EFDO-<italic>cls</italic></td>
<td align="left" valign="top"><italic>Enterococcus faecalis</italic> ATCC 29212 harboring plasmid pDL278 that carries site-directed mutated <italic>cls</italic> gene originated from <italic>E. faecium</italic> DO</td>
</tr>
<tr>
<td align="left" valign="top">EF332-<italic>gdpD</italic></td>
<td align="left" valign="top"><italic>Enterococcus faecalis</italic> ATCC 29212 harboring plasmid pDL278 that carries <italic>gdpD</italic> gene originated from <italic>E. faecium</italic> EF332</td>
</tr>
<tr>
<td align="left" valign="top">EFDO-<italic>gdpD</italic></td>
<td align="left" valign="top"><italic>Enterococcus faecalis</italic> ATCC 29212 harboring plasmid pDL278 that carries site-directed mutated <italic>gdpD</italic> gene originated from <italic>E. faecium</italic> DO</td>
</tr>
<tr>
<td align="left" valign="top">29,212-pDL278</td>
<td align="left" valign="top"><italic>Enterococcus faecalis</italic> ATCC 29212 harboring shuttle plasmid pDL278</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="sec8">
<title>Site-Directed Mutagenesis</title>
<p>In order to further confirm the role of mutations in <italic>cls</italic> and <italic>gdpD</italic> genes, site-directed mutagenesis was performed using overlap extension PCR (SOE-PCR; <xref ref-type="bibr" rid="ref26">Ho et al., 1989</xref>). The <italic>cls</italic> gene was divided into four fragments at three mutated sites, and <italic>gdpD</italic> gene was divided into two fragments at one mutated site. The primers used are shown in <xref ref-type="supplementary-material" rid="SM1">Supplementary Table 1</xref>.</p>
<p>The SOE-PCR process consisted of two consecutive reactions. First-round PCR: Genomic DNA of <italic>E. faecium</italic> EF332 was used as a template to obtain the corresponding gene fragments. PCR products obtained were purified using the DNA purification kit (TIANGEN, Beijing, China). Second-round PCR: The purified PCR products obtained from the previous step were used as templates, and corresponding primers were added to the reaction system for amplification.</p>
<p>These point mutations led to the amino acid substitutions T269I, V203I, T298S in Cls, and S201P in GdpD. Plasmids carrying these mutated gene fragments were transformed to obtain EFDO-<italic>cls</italic> and EFDO-<italic>gdpD</italic> strains by the method described above.</p>
</sec>
<sec id="sec9">
<title>Analysis of Membrane Surface Charge</title>
<p>Poly-<sub>L</sub>-lysine conjugated to fluorescein isothiocyanate (PLL:FITC) was used to assay cell surface charges according to previous studies (<xref ref-type="bibr" rid="ref47">Prater et al., 2021</xref>). In brief, the strains grew until OD<sub>600</sub> reached 0.5 in TSB. Cells were then washed three times with sterilized HEPES buffer (20&#x2009;mM, pH 7.0) and diluted to OD<sub>600</sub> of 0.1. Cells were incubated with 50&#x2009;&#x03BC;g/ml PLL:FITC (final concentration) at room temperature with shaking for 10&#x2009;min and were then washed once using HEPES buffer to remove unbound PLL:FITC. Treated cells were spread on poly-<sub>L</sub>-lysine-treated glass slides, followed by the addition of 20&#x2009;&#x03BC;l fluorescent anti-quenching agent. Fluorescence images were observed under NIKON Ti-E inverted fluorescence microscope (Nikon Instruments Co., LTD, Japan) and quantified by ImageJ, with duplicates per strain.</p>
</sec>
<sec id="sec10">
<title>Observation of Cardiolipin Distribution on CM</title>
<p>The fluorescent probe 10-<italic>N</italic>-nonyl acridine orange (NAO) specifically binds to cardiolipin, and the change of cardiolipin distribution caused by <italic>cls</italic> mutation can be determined by observing the NAO fluorescence distribution on the membrane (<xref ref-type="bibr" rid="ref42">Mileykovskaya et al., 2001</xref>). NAO fluorescence assay was performed according to previous studies (<xref ref-type="bibr" rid="ref62">Tran et al., 2013b</xref>). In brief, the bacteria were activated in TSB overnight and transferred to new TSB to grow to exponential phase (OD<sub>600</sub> of ~0.5), after which NAO was added to the medium at a final concentration of 2.5&#x2009;&#x03BC;M. The sample was oscillated at 100&#x2009;rpm and 37&#x00B0;C for 4&#x2009;h under dark conditions. The cells were washed three times (5,000&#x2009;rpm, 3&#x2009;min) with sterilized 0.9% saline and immediately mixed with 2&#x00D7; volume of fluorescent anti-quenching agent and fixed on the poly-<sub>L</sub>-lysine-treated glass slides. Fluorescence observation was performed using a laser scanning confocal microscope with 100&#x00D7; objective and airyscan detector (LSM880, ZEISIS, Germany).</p>
</sec>
<sec id="sec11">
<title>CM Lipid Analysis</title>
<p>Membrane lipids were extracted using previous methods (<xref ref-type="bibr" rid="ref34">Komagata and Suzuki, 1988</xref>). The lipid components of tested strains were separated by two-dimensional thin-layer chromatography (2D-TLC, Silica 60 F254 TLC plates; Merck) and stained with phosphomolybdic acid (blue for all lipids) and ninhydrin (red for lipids with amino groups), respectively, with three replicates for each strain. The first dimension was developed with chloroform/methanol/water (65:25:4, by volume), and the second dimension was developed with chloroform/acetic acid/methanol/water (80:15:12:4, by volume). The dried TLC plates were heated for 15&#x2009;min in a 110&#x00B0;C oven to find phospholipid composition.</p>
</sec>
<sec id="sec12">
<title>Transmission Electron Microscopy</title>
<p>Bacteria were inoculated in 30-ml TSB and grew to exponential phase by shaking at 160&#x2009;rpm and 37&#x00B0;C. The cultures were centrifuged at 5,000&#x2009;rpm for 3&#x2009;min to pellet cells. Cells were fixed at 4&#x00B0;C for 1&#x2009;h with 500&#x2009;&#x03BC;l 2.5% glutaraldehyde, washed with PBS (pH 7.2, 0.01 M) for five times (20&#x2009;min each), fixed with 1% osmium acid at 4&#x00B0;C for 1&#x2009;h, and washed with PBS (pH 7.2, 0.01 M) for three times, 15&#x2009;min each. The samples were sequentially dehydrated with 30, 50, 70, 90, and 100% ethanol (twice) and replaced twice by acetone, 15&#x2009;min each time. Different proportions of embedding agent (EPON812: acetone =1:3,1:1,3:1) were used to penetrate for 1&#x2009;h successively, and then, pure embedding agent (100% EPON812) was used for penetration overnight. The samples were embedded in EPON812 and then subjected to temperature-programmed curing for 48&#x2009;h before ultra-thin section. The sections were stained with 2% uranium acetate solution for 20&#x2009;min (in dark), washed with ddH<sub>2</sub>O three times for 5&#x2009;min each, stained with 1% lead citrate solution for 10&#x2009;min, and then washed with ddH<sub>2</sub>O three times for 5&#x2009;min each. The prepared samples were observed by Focused Ion Beam-Scanning Transmission Electron Microscope (Crossbeam 550, ZEISIS, Germany).</p>
</sec>
<sec id="sec13">
<title>Quantitative Polymerase Chain Reactions</title>
<p>qPCRs were used to assay the copy numbers of pDL278 vector and variants in <italic>E. faecium</italic> strains (29212-pDL278, EFDO-<italic>cls</italic>, EF332-<italic>cls</italic>) to verify the stability of this vector. Plasmid levels were calculated using the 2<sup>&#x2212;&#x0394;&#x0394;<italic>C</italic>t</sup> method. 16S rDNA was used as the housekeeping gene. The primers used are listed in <xref ref-type="supplementary-material" rid="SM1">Supplementary Table 1</xref>. The qPCR system (20&#x2009;&#x03BC;l) contains the following: 10&#x2009;&#x03BC;l of 2&#x00D7; SYBR green premix pro taq HS premix (Accurate Biotechnology Co., Ltd., China), 7.8&#x2009;&#x03BC;l dd H<sub>2</sub>O, 0.4&#x2009;&#x03BC;l of forward and reverse primers each (10&#x2009;&#x03BC;M), 0.4&#x2009;&#x03BC;l of ROX reference dye (20&#x2009;&#x03BC;M, Accurate Biotechnology Co., Ltd., China), and 1&#x2009;&#x03BC;l template DNA (100&#x2009;ng/&#x03BC;l). The qPCRs were performed with the following programs: denaturation at 95&#x00B0;C for 30&#x2009;s, followed by 40 cycles of denaturation at 95&#x00B0;C for 5&#x2009;s, annealing at 60&#x00B0;C for 30&#x2009;s. Three biological replicates were performed for each sample, and each qPCR was conducted in triplicate using the ABI StepOnePlus system (Applied Biosystems Inc., Waltham, MA, United States).</p>
</sec>
<sec id="sec14">
<title>Survival Assay</title>
<p>Survival analysis was performed according to the previously published method to compare the survival of different strains under daptomycin stress (<xref ref-type="bibr" rid="ref22">Grein et al., 2020</xref>). After the bacteria grew to exponential phase (OD<sub>600</sub>&#x2009;=&#x2009;0.5) in 5&#x2009;ml M&#x00FC;ller Hinton broth containing 0.05&#x2009;g/L Ca<sup>2+</sup> (CAMHB), 100&#x2009;&#x03BC;l of the cultures were diluted 10<sup>5</sup>-fold. One hundred microliters of the diluted bacterial solution was inoculated on TSB agar plates (three replications) for CFU calculation. The remaining cultures were incubated with 32&#x2009;&#x03BC;g/ml (4 &#x00D7;&#x2009;MIC) daptomycin (final concentration) at 37&#x00B0;C with shaking at 180&#x2009;rpm for 1&#x2009;h. During incubation, 100&#x2009;&#x03BC;l cultures were taken every 15&#x2009;min, diluted, and counted as described above. In order to avoid the influence of the change of bacterial solution volume during incubation, an equal volume of CAMHB was added after 100&#x2009;&#x03BC;l bacterial solution was taken each time. Colony counts at different time points were recorded after overnight incubation at 37&#x00B0;C, and survival rate was calculated as the percentage of colony counts to those without treatment of daptomycin.</p>
</sec>
<sec id="sec15">
<title>Bioinformatics</title>
<p>Whole-genome sequencing reads were assembled into a preliminary genome using SMRT Link v5.1.0 software (<xref ref-type="bibr" rid="ref1">Ardui et al., 2018</xref>), and arrow software was used to optimize the assembly results. The optimized assembly results were analyzed and compared with original data to discriminate chromosomes and plasmid sequences. Final circular genomes were obtained, followed by gene prediction using GeneMarkS v4.17 software (<xref ref-type="bibr" rid="ref8">Besemer et al., 2001</xref>). Genomic Islands (GIs) were predicted using IslandPath-DIOMB v0.12 software (<xref ref-type="bibr" rid="ref28">Hsiao et al., 2003</xref>). Prophage prediction was completed by online prediction server PHASTER (<xref ref-type="bibr" rid="ref66">Zhou et al., 2011</xref>; <xref ref-type="bibr" rid="ref4">Arndt et al., 2016</xref>). Functional annotation of coding genes was performed using GO (<xref ref-type="bibr" rid="ref5">Ashburner et al., 2000</xref>), COG (<xref ref-type="bibr" rid="ref20">Galperin et al., 2014</xref>), NR (<xref ref-type="bibr" rid="ref40">Li et al., 2002</xref>), Pfam (<xref ref-type="bibr" rid="ref49">Punta et al., 2011</xref>), TCDB (<xref ref-type="bibr" rid="ref52">Saier et al., 2013</xref>), and SWISS-PROT (<xref ref-type="bibr" rid="ref6">Bairoch and Apweiler, 2000</xref>) databases. ARG annotation used Resistance Gene Identifier (RGI) v5.1.0 software provided by CARD database (<xref ref-type="bibr" rid="ref31">Jia et al., 2016</xref>). Multilocus sequence typing (MLST) and plasmid classification of <italic>E. faecium</italic> EF332 were performed using MLST<xref rid="fn0004" ref-type="fn"><sup>1</sup></xref> and PlasmidFinder databases,<xref rid="fn0005" ref-type="fn"><sup>2</sup></xref> respectively, provided by Center for Genomic Epidemiology. AlphaFold 2 software was used to construct Cls structure model (<xref ref-type="bibr" rid="ref32">Jumper et al., 2021</xref>). Pfam database was used to predict Cls protein domain structure (<xref ref-type="bibr" rid="ref44">Mistry et al., 2021</xref>), and DOG 2.0 software was used to draw the protein domain structure map (<xref ref-type="bibr" rid="ref51">Ren et al., 2009</xref>). The relative intensity of fluorescence was quantified by ImageJ 1.52a, resulting in the mean of two biological duplicates, and the significance level was analyzed by Student&#x2019;s <italic>t</italic>-test. The ggplot2 package in R Studio 1.3.929 software (based on R 3.6.3) was used to draw the box charts of fluorescence intensity, and the gggenes and ggplot2 packages were used to generate the gene structure diagrams.</p>
</sec>
</sec>
<sec id="sec16" sec-type="results">
<title>Results</title>
<sec id="sec17">
<title>Isolation and Identification of a Vancomycin- and Daptomycin-Resistant <italic>Enterococcus faecium</italic> EF332 Strain</title>
<p><italic>Enterococcus faecium</italic> EF332 strain used in this study was isolated in the Laboratory Medicine Center of the Second Hospital of Shandong University during routine screening of pathogens. Antimicrobial susceptibility tests were performed for this strain using 13 antibiotics in 10 classes by both Kirby&#x2013;Bauer disk diffusion method and determination of minimum inhibitory concentration (MIC) levels. It was shown that <italic>E. faecium</italic> EF332 was resistant to most antibiotics (<xref rid="tab2" ref-type="table">Table 2</xref>), suggesting that it is multidrug-resistant. A striking observation is that <italic>E. faecium</italic> EF332 is resistant to both last-line antibiotics against enterococcal infections: vancomycin and daptomycin (<xref ref-type="bibr" rid="ref7">Bender et al., 2018</xref>). This unusual phenomenon drove us to further investigate the mechanisms underlying multidrug resistance of this strain, particularly for the two last-resort antibiotics vancomycin and daptomycin.</p>
<table-wrap position="float" id="tab2">
<label>Table 2</label>
<caption><p>Antibiotic susceptibility of <italic>Enterococcus faecium</italic> EF332.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Antibiotics class</th>
<th align="center" valign="top">Antibiotic</th>
<th align="center" valign="top">Inhibition zone (mm)</th>
<th align="center" valign="top">MIC (&#x03BC;g/ml)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">Ansamycins</td>
<td align="center" valign="top">RIF</td>
<td align="center" valign="top">11 (R)</td>
<td align="center" valign="top">4 (R)</td>
</tr>
<tr>
<td align="left" valign="top">Macrolides</td>
<td align="center" valign="top">ERY</td>
<td align="center" valign="top">0 (R)</td>
<td align="center" valign="top">&#x003E;256 (R)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="2">Fluoroquinolones</td>
<td align="center" valign="top">CIP</td>
<td align="center" valign="top">0 (R)</td>
<td align="center" valign="top">32 (R)</td>
</tr>
<tr>
<td align="center" valign="top">GAT</td>
<td align="center" valign="top">0 (R)</td>
<td align="center" valign="top">32 (R)</td>
</tr>
<tr>
<td align="left" valign="top">Phenicols</td>
<td align="center" valign="top">CHL</td>
<td align="center" valign="top">21 (S)</td>
<td align="center" valign="top">4 (S)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="2">Tetracyclines</td>
<td align="center" valign="top">TET</td>
<td align="center" valign="top">10 (R)</td>
<td align="center" valign="top">32 (R)</td>
</tr>
<tr>
<td align="center" valign="top">TGC</td>
<td align="center" valign="top">22 (S)</td>
<td align="center" valign="top">0.0375 (S)</td>
</tr>
<tr>
<td align="left" valign="top">Glycopeptides</td>
<td align="center" valign="top">VAN</td>
<td align="center" valign="top">0 (R)</td>
<td align="center" valign="top">128 (R)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="2">&#x03B2;-lactams</td>
<td align="center" valign="top">PEN</td>
<td align="center" valign="top">0 (R)</td>
<td align="center" valign="top">&#x003E;256 (R)</td>
</tr>
<tr>
<td align="center" valign="top">AMP</td>
<td align="center" valign="top">0 (R)</td>
<td align="center" valign="top">&#x003E;256 (R)</td>
</tr>
<tr>
<td align="left" valign="top">Lipopeptides</td>
<td align="center" valign="top">DAP</td>
<td align="center" valign="top">n.a.</td>
<td align="center" valign="top">8 (R)</td>
</tr>
<tr>
<td align="left" valign="top">Fosfomycins</td>
<td align="center" valign="top">FOF</td>
<td align="center" valign="top">34 (S)</td>
<td align="center" valign="top">64 (S)</td>
</tr>
<tr>
<td align="left" valign="top">Oxazolidinones</td>
<td align="center" valign="top">LZD</td>
<td align="center" valign="top">23 (S)</td>
<td align="center" valign="top">1 (S)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p>n.a.: K-B disk diffusion method is unavailable in both CLSI and EUCAST standards. RIF, rifampicin; ERY, erythromycin; CIP, ciprofloxacin; GAT, gatifloxacin; CHL, chloramphenicol; TET, tetracycline; TGC, tigecycline; VAN, vancomycin; PEN, penicillin; AMP, ampicillin; DAP, daptomycin; FOF, fosfomycin; LZD, linezolid; R, resistant; S, sensitive.</p>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec18">
<title>Multidrug-Resistant Determinants of <italic>Enterococcus faecium</italic> EF332 Revealed by Whole-Genome Sequencing</title>
<p>To fully understand the genetic basis of multidrug resistance in <italic>E. faecium</italic> EF332, whole-genome sequences were obtained with third-generation PacBio sequencing accompanied by second-generation Illumina sequencing (The sequencing data were deposited in GenBank with accession numbers CP058891-CP058895). Full sequences for a circular chromosome and four plasmids were obtained. The size of the chromosome is 2,755,510&#x2009;bp, similarly to previously sequenced <italic>E. faecium</italic> strains. The four plasmids, pEF332-1, pEF332-2, pEF332-3, and pEF332-4, are, respectively, 12,341, 87,675p, 28,308, and 203,652&#x2009;bp long (<xref ref-type="supplementary-material" rid="SM4">Supplementary Figure 1</xref>; <xref ref-type="supplementary-material" rid="SM2">Supplementary Table 2</xref>). Multilocus sequence typing (MLST) result showed that <italic>E. faecium</italic> EF332 belongs to ST192, one type of the CC17 clone complex (clade A1), which is believed to have evolved in infections of hospital environment (<xref ref-type="bibr" rid="ref19">Freitas et al., 2010</xref>).</p>
<p>With accurate gene prediction algorithms, a total of 3,121 genes were predicted to be encoded by <italic>E. faecium</italic> EF332, of which 2,735 are chromosome-borne and 386 are plasmid-borne (<xref ref-type="supplementary-material" rid="SM2">Supplementary Table 2</xref>). Annotation with Comprehensive Antibiotic Resistance Database (CARD) showed that 9, 0, 12, 0, and 2 ARGs were encoded on the chromosome, pEF332-1, pEF332-2, pEF332-3, and pEF332-4, respectively (<xref rid="tab3" ref-type="table">Table 3</xref>; <xref ref-type="supplementary-material" rid="SM2">Supplementary Table 2</xref>). Determinants for all antibiotics were found, most of which are chromosome-borne. Only pEF332-2 and pEF332-4 are antibiotic-resistant plasmids. While pEF332-4 only carries ARGs for aminoglycosides and was previously found in <italic>E. faecium</italic> VRE1 (<xref ref-type="bibr" rid="ref58">Sun et al., 2020</xref>), pEF332-2 is a new plasmid that carries both <italic>vanA</italic> and <italic>vanM</italic> gene clusters. To the best of our knowledge, plasmids carrying both <italic>vanA</italic> and <italic>vanM</italic> genes are very rare, and only one such plasmid (pELF1) has been found so far in Japan, which is associated with high vancomycin resistance and high risk of transmission (<xref ref-type="bibr" rid="ref23">Hashimoto et al., 2019</xref>). pEF332-2 is therefore the second plasmid that bears both <italic>vanA</italic> and <italic>vanM</italic> clusters identified so far. This is also in consistency with the high level of vancomycin resistance (128&#x2009;&#x03BC;g/ml) observed with <italic>E. faecium</italic> EF332. In addition, <italic>vanA</italic> gene clusters are encoded on a genomic island GIs011 that is also part of a multidrug-resistant prophage (<xref rid="fig1" ref-type="fig">Figure 1</xref>; <xref ref-type="supplementary-material" rid="SM2">Supplementary Table 3</xref>). This is a strong implication that these ARGs are acquired by horizontal gene transfer. Therefore, this new pEF332-2 plasmid is a strong vancomycin-resistant plasmid that also has a strong implication for ARG mobility. Further phylogenetic analysis of <italic>E. faecium</italic> EF332 plasmids and 55 other plasmids, along with subtyping of pEF332-2 with PlasmidFinder, suggests pEF332-2 belongs to type rep2 (<xref rid="fig2" ref-type="fig">Figure 2</xref>). Previous report suggested type rep2 plasmids originate from a variety of sources, including hospitals, poultry, and foods (<xref ref-type="bibr" rid="ref53">Schwarz et al., 2001</xref>; <xref ref-type="bibr" rid="ref54">Sletvold et al., 2007</xref>; <xref ref-type="bibr" rid="ref58">Sun et al., 2020</xref>), suggesting that these plasmids may spread between multiple environments. Nevertheless, attempts to transfer pEF332-2 from the host <italic>E. faecium</italic> EF332 strain to another bacterium <italic>via</italic> conjugation or transformation were unsuccessful, showing the limited efficiency of horizontal gene transfer.</p>
<table-wrap position="float" id="tab3">
<label>Table 3</label>
<caption><p>Predicted antimicrobial resistance determinants in <italic>Enterococcus faecium</italic> EF332 with CARD.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Antibiotics class</th>
<th align="left" valign="top">Chromosome</th>
<th align="left" valign="top">pEF332-2</th>
<th align="left" valign="top">pEF332-4</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top" rowspan="2">Fluoroquinolones</td>
<td align="left" valign="top"><italic>gyrA</italic> mutation</td>
<td/>
<td/>
</tr>
<tr>
<td align="left" valign="top"><italic>gyrB</italic> mutation</td>
<td/>
<td/>
</tr>
<tr>
<td align="left" valign="top">Elfamycins/kirromycins</td>
<td align="left" valign="top"><italic>EF-Tu</italic> mutation</td>
<td/>
<td/>
</tr>
<tr>
<td align="left" valign="top" rowspan="2">Lipopeptides</td>
<td align="left" valign="top"><italic>cls</italic> mutation<xref rid="tfn1" ref-type="table-fn"><italic><sup>&#x002A;</sup></italic></xref>
</td>
<td/>
<td/>
</tr>
<tr>
<td align="left" valign="top"><italic>gdpD</italic> mutation<xref rid="tfn1" ref-type="table-fn"><italic><sup>&#x002A;</sup></italic></xref>
</td>
<td/>
<td/>
</tr>
<tr>
<td align="left" valign="top">Peptide/ansamycins antibiotics</td>
<td align="left" valign="top"><italic>rpoB</italic></td>
<td/>
<td/>
</tr>
<tr>
<td align="left" valign="top">Diaminopyrimidines</td>
<td align="left" valign="top"><italic>dfrE</italic></td>
<td/>
<td/>
</tr>
<tr>
<td align="left" valign="top">Tetracyclines</td>
<td align="left" valign="top"><italic>tetM</italic></td>
<td/>
<td/>
</tr>
<tr>
<td align="left" valign="top" rowspan="2">Aminoglycosides</td>
<td align="left" valign="top" rowspan="2"><italic>AAC(6&#x2032;)-Ii</italic></td>
<td align="left" valign="top" rowspan="2"><italic>APH(3&#x2032;)-IIIa</italic></td>
<td align="left" valign="top"><italic>AAC(6&#x2032;)-Ie-APH(2&#x2033;)-Ia1</italic></td>
</tr>
<tr>
<td align="left" valign="top"><italic>AAC(6&#x2032;)-Ie-APH(2&#x2033;)-Ia2</italic></td>
</tr>
<tr>
<td align="left" valign="top">Macrolides/lincosamides/streptogramins</td>
<td/>
<td align="left" valign="top"><italic>ermB</italic></td>
<td/>
</tr>
<tr>
<td align="left" valign="top" rowspan="10">Glycopeptides</td>
<td/>
<td align="left" valign="top"><italic>vanM</italic></td>
<td/>
</tr>
<tr>
<td/>
<td align="left" valign="top"><italic>vanHM</italic></td>
<td/>
</tr>
<tr>
<td/>
<td align="left" valign="top"><italic>vanYM</italic></td>
<td/>
</tr>
<tr>
<td/>
<td align="left" valign="top"><italic>vanSM</italic></td>
<td/>
</tr>
<tr>
<td/>
<td align="left" valign="top"><italic>vanRM</italic></td>
<td/>
</tr>
<tr>
<td/>
<td align="left" valign="top"><italic>vanA</italic></td>
<td/>
</tr>
<tr>
<td/>
<td align="left" valign="top"><italic>vanSA</italic></td>
<td/>
</tr>
<tr>
<td/>
<td align="left" valign="top"><italic>vanHA</italic></td>
<td/>
</tr>
<tr>
<td/>
<td align="left" valign="top"><italic>vanXA</italic></td>
<td/>
</tr>
<tr>
<td/>
<td align="left" valign="top"><italic>vanRA</italic></td>
<td/>
</tr>
<tr>
<td align="left" valign="top">Total</td>
<td align="left" valign="top">9</td>
<td align="left" valign="top">12</td>
<td align="left" valign="top">2</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="tfn1">
<label>&#x002A;</label>
<p>Genes associated with DAP resistance.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<fig position="float" id="fig1">
<label>Figure 1</label>
<caption><p>Genetic organization of prophage in pEF332-2.</p></caption>
<graphic xlink:href="fmicb-13-896916-g001.tif"/>
</fig>
<fig position="float" id="fig2">
<label>Figure 2</label>
<caption><p>Phylogenetic analysis of <italic>rep</italic> genes of <italic>Enterococcus faecium</italic> EF332 plasmids. The bootstrap values are displayed on the branches with 1,000 times of replications. Bar, evolutionary distance.</p></caption>
<graphic xlink:href="fmicb-13-896916-g002.tif"/>
</fig>
<p>While comparing the genomic sequences of <italic>E. faecium</italic> EF332 and daptomycin-sensitive <italic>E. faecium</italic> DO strain, mutations were found on <italic>cls</italic> and <italic>gdpD</italic> that, respectively, encode cardiolipin synthase and glycerophosphoryl diester phosphodiesterase (<xref rid="tab4" ref-type="table">Table 4</xref>). It was previously reported that mutations in these genes can lead to daptomycin resistance (<xref ref-type="bibr" rid="ref29">Humphries et al., 2012</xref>; <xref ref-type="bibr" rid="ref15">Davlieva et al., 2013</xref>; <xref ref-type="bibr" rid="ref33">Kelesidis et al., 2013</xref>; <xref ref-type="bibr" rid="ref39">Lellek et al., 2015</xref>; <xref ref-type="bibr" rid="ref48">Prater et al., 2019</xref>). However, known mutations that confer DAP resistance on these genes were not present in <italic>E. faecium</italic> EF332, leading to the hypothesis that new mutations of the two genes could lead to daptomycin resistance.</p>
<table-wrap position="float" id="tab4">
<label>Table 4</label>
<caption><p>Mutations in <italic>cls</italic> and <italic>gdpD</italic> that are associated with DAP resistance.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Genes</th>
<th align="left" valign="top">Mutations</th>
<th align="left" valign="top">References</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top"><italic>cls</italic></td>
<td align="left" valign="top">N13I, H215R, R218Q, +MPL110-112</td>
<td align="left" valign="top">
<xref ref-type="bibr" rid="ref3">Arias et al., 2011</xref>
</td>
</tr>
<tr>
<td align="left" valign="top"><italic>cls</italic></td>
<td align="left" valign="top">N13T, K59T</td>
<td align="left" valign="top">
<xref ref-type="bibr" rid="ref33">Kelesidis et al., 2013</xref>
</td>
</tr>
<tr>
<td align="left" valign="top"><italic>cls</italic></td>
<td align="left" valign="top">H215R, R218Q</td>
<td align="left" valign="top">
<xref ref-type="bibr" rid="ref15">Davlieva et al., 2013</xref>
</td>
</tr>
<tr>
<td align="left" valign="top"><italic>cls</italic></td>
<td align="left" valign="top">H215R</td>
<td align="left" valign="top">
<xref ref-type="bibr" rid="ref29">Humphries et al., 2012</xref>
</td>
</tr>
<tr>
<td align="left" valign="top"><italic>cls</italic></td>
<td align="left" valign="top">A20D, D27N, R218Q, R267H</td>
<td align="left" valign="top">
<xref ref-type="bibr" rid="ref39">Lellek et al., 2015</xref>
</td>
</tr>
<tr>
<td align="left" valign="top"><italic>cls</italic></td>
<td align="left" valign="top">I203V, I269T, S298T</td>
<td align="left" valign="top">This study</td>
</tr>
<tr>
<td align="left" valign="top"><italic>gdpD</italic><xref rid="tfn2" ref-type="table-fn"><italic><sup>a</sup></italic></xref>
</td>
<td align="left" valign="top">H29R</td>
<td align="left" valign="top">
<xref ref-type="bibr" rid="ref48">Prater et al., 2019</xref>
</td>
</tr>
<tr>
<td align="left" valign="top"><italic>gdpD</italic></td>
<td align="left" valign="top">P201S</td>
<td align="left" valign="top">This study</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="tfn2">
<label>a</label>
<p>This mutation was found in DAP-resistant <italic>Enterococcus faecium</italic> but has not been shown to confer DAP resistance.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec19">
<title>New <italic>cls</italic> Mutations Lead to Daptomycin Resistance in <italic>Enterococcus faecium</italic> EF332</title>
<p>In order to find out which mutations on <italic>cls</italic> and/or <italic>gdpD</italic> lead to daptomycin resistance in <italic>E. faecium</italic> EF332 strains, a series of clones were constructed using daptomycin-sensitive <italic>E. faecalis</italic> ATCC 29212 as the parent strain: the EF332-<italic>cls</italic> strain that harbors <italic>cls</italic> from <italic>E. faecium</italic> EF332; the EFDO-<italic>cls</italic> strain that harbors <italic>cls</italic> from <italic>E. faecium</italic> EF332 with identified mutations (V<sub>203</sub>, T<sub>269</sub>, T<sub>298</sub>) reverted to I<sub>203</sub>, I<sub>269</sub>, and S<sub>298</sub>; the EF332-<italic>gdpD</italic> strain that harbors <italic>gdpD</italic> from <italic>E. faecium</italic> EF332; and the EFDO-<italic>gdpD</italic> strain that harbors <italic>gdpD</italic> from <italic>E. faecium</italic> EF332 with identified mutation S<sub>201</sub> reverted to P<sub>201</sub>; the 29212-pDL278 strain that harbors pDL278 empty vector as control for constructed strains (<xref rid="tab1" ref-type="table">Table 1</xref>). It is shown that the DAP MIC of <italic>E. faecalis</italic> ATCC 29212 increased from 1 to 8 with the introduction of pDL278 vector (<xref ref-type="supplementary-material" rid="SM2">Supplementary Table 4</xref>). A twofold increase in MIC values for daptomycin was found for EF332-<italic>cls</italic> strain (16&#x2009;&#x03BC;g/ml) over the EFDO-<italic>cls</italic> strain (8&#x2009;&#x03BC;g/ml), whereas no change of MIC values for daptomycin was found for EF332-<italic>gdpD</italic> strain (8&#x2009;&#x03BC;g/ml) over the EFDO-<italic>gdpD</italic> strain (8&#x2009;&#x03BC;g/ml; <xref ref-type="supplementary-material" rid="SM2">Supplementary Table 4</xref>). These results suggest that mutations in <italic>cls</italic> can lead to daptomycin resistance, while mutations in <italic>gdpD</italic> cannot.</p>
<p>Further susceptibility tests including K-B disk diffusion assays and survival assays support this finding. The inhibition zones of daptomycin with the EF332-<italic>cls</italic> strain are significantly smaller than the EFDO-<italic>cls</italic> strain (<italic>p&#x2009;=</italic> 2.09 &#x00D7;&#x2009;10<sup>&#x2212;5</sup>, <xref rid="fig3" ref-type="fig">Figure 3</xref>), while no significant difference was found between EFDO-<italic>cls</italic> strain and 29212-pDL278. Similarly, in survival assays, a significantly higher daptomycin resistance strength was found for EF332-<italic>cls</italic> in comparison with EFDO-<italic>cls</italic>, while EFDO-<italic>cls</italic> and 29212-pDL278 respond to daptomycin stress similarly (<xref rid="fig4" ref-type="fig">Figure 4</xref>). Additional analysis of plasmid copy numbers confirmed that introducing variants of <italic>cls</italic> did not lead to plasmid copy number fluctuation (<xref rid="fig5" ref-type="fig">Figure 5</xref>). It is further interesting to find that in both liquid-media-based analyses, aka the MIC determination and survival analysis, pDL278 introduction increased daptomycin resistance (<xref rid="fig4" ref-type="fig">Figure 4</xref>), while in the plate-based K-B disk diffusion assay, pDL278 introduction led to little difference in daptomycin resistance (<xref rid="fig3" ref-type="fig">Figure 3</xref>). This prompted us to hypothesize that maybe pDL278 can result in growth status-specific response to daptomycin, but without further evidence we cannot suggest the specific mechanism behind this phenomenon. Despite this difference, in all scenarios and in all assays, introducing <italic>cls</italic> from <italic>E. faecium</italic> EF332 leads to significantly stronger daptomycin resistance than introducing <italic>cls</italic> from <italic>E. faecium</italic> DO, confirming the above suggestion that mutations in <italic>cls</italic> found in <italic>E. faecium</italic> EF332 lead to daptomycin resistance.</p>
<fig position="float" id="fig3">
<label>Figure 3</label>
<caption><p>Susceptibility tests of strains based on K-B disk diffusion method. 29212, <italic>Enterococcus faecalis</italic> ATCC 29212; <sup>&#x002A;&#x002A;&#x002A;</sup><italic>p</italic>&#x003C;0.001; bar, standard deviation.</p></caption>
<graphic xlink:href="fmicb-13-896916-g003.tif"/>
</fig>
<fig position="float" id="fig4">
<label>Figure 4</label>
<caption><p>Daptomycin survival assays of <italic>Enterococcus faecalis</italic> strains. 29212, <italic>E. faecalis</italic> ATCC 29212; bar, standard deviation.</p></caption>
<graphic xlink:href="fmicb-13-896916-g004.tif"/>
</fig>
<fig position="float" id="fig5">
<label>Figure 5</label>
<caption><p>Relative plasmid copy numbers. Relative plasmid copy numbers are defined as relative normalized plasmid copy numbers to 29212-pDL278 strain. Bar, standard deviation; n.s., not significant.</p></caption>
<graphic xlink:href="fmicb-13-896916-g005.tif"/>
</fig>
</sec>
<sec id="sec20">
<title>Impact of <italic>cls</italic> and <italic>gdpD</italic> Mutations on Membrane Properties</title>
<p>Both <italic>cls</italic> and <italic>gdpD</italic> genes are related to phospholipid metabolism in CM: The <italic>cls</italic> gene encodes cardiolipin synthase, and <italic>gdpD</italic> gene encodes glycerophosphoryl diester phosphodiesterase (<xref ref-type="bibr" rid="ref3">Arias et al., 2011</xref>). We therefore hypothesized that mutations in these two genes alter membrane properties, which in turn leads to alteration in membrane&#x2013;daptomycin interactions. To confirm this, two-dimensional thin-layer chromatography (2D-TLC) was performed to analyze the changes of membrane lipids components caused by mutations. As shown in <xref rid="fig6" ref-type="fig">Figure 6</xref>, mutation in <italic>gdpD</italic> altered the aminolipid composition of CM, while mutations in <italic>cls</italic> did not significantly alter the lipid composition of CM. This finding suggests a putative role of <italic>gdpD</italic> in the biosynthesis of relatively poorly characterized aminolipid. Furthermore, membrane surface charges were quantified using positively charged fluorescence dye poly-<sub>L</sub>-lysine conjugated to fluorescein isothiocyanate (PLL: FITC). A significant reduction of binding to PLL: FITC was found between EF332-<italic>cls</italic> and <italic>E. faecalis</italic> ATCC 29212 (<italic>p</italic>&#x2009;=&#x2009;6.27&#x2009;&#x00D7;&#x2009;10<sup>&#x2212;65</sup>), as well as between EF332-<italic>cls</italic> and EFDO-<italic>cls</italic> (<italic>p</italic>&#x2009;=&#x2009;2.20&#x2009;&#x00D7;&#x2009;10<sup>&#x2212;101</sup>; <xref rid="fig7" ref-type="fig">Figure 7</xref>). This significant change suggests that a reduction of membrane negative charges followed <italic>cls</italic> mutations, which can lead to weakened binding of positively charged DAP-Ca<sup>2+</sup> to the membrane, the target for the bactericidal effect of daptomycin. This finding suggests that <italic>cls</italic> mutations lead to daptomycin resistance by reduction of membrane negative charges. Only minor changes of membrane negative potentials were found for <italic>gdpD</italic> mutation strain (<xref rid="fig7" ref-type="fig">Figure 7</xref>), in consistent with the finding that <italic>gdpD</italic> mutation did not lead to increase of daptomycin resistance.</p>
<fig position="float" id="fig6">
<label>Figure 6</label>
<caption><p>Two-dimensional thin-layer chromatography of phospholipids in <italic>Enterococcus faecium</italic> EF332 strains. Panels <bold>(A&#x2013;D)</bold> are results of phosphomolybdic acid staining, and all lipids are dyed blue; Panels <bold>(E&#x2013;H)</bold> are results of ninhydrin staining, and aminolipids are dyed red. Panels <bold>(A,E)</bold> EFDO-<italic>cls</italic>; Panels <bold>(B,F)</bold> EF332-<italic>cls</italic>; Panels <bold>(C,G)</bold> EFDO-<italic>gdpD</italic>; Panels <bold>(D,H)</bold> EF332-<italic>gdpD</italic>. DPG: diphosphatidyl glycerol (cardiolipin); AL, aminolipids; L1&#x2013;L5, lipids.</p></caption>
<graphic xlink:href="fmicb-13-896916-g006.tif"/>
</fig>
<fig position="float" id="fig7">
<label>Figure 7</label>
<caption><p>Cell surface charge measured with PLL: FITC fluorescence. 29212, <italic>Enterococcus faecalis</italic> ATCC 29212, <sup>&#x002A;&#x002A;&#x002A;</sup><italic>p</italic>&#x2009;&#x003C;0.001.</p></caption>
<graphic xlink:href="fmicb-13-896916-g007.tif"/>
</fig>
<p>We further sought to investigate whether <italic>cls</italic> mutations also alter the distribution of cardiolipin produced by <italic>cls</italic>-encoded cardiolipin synthase. A specific cardiolipin binding fluorescent probe, 10-<italic>N</italic>-nonyl acridine orange (NAO), was used to observe the distribution of cardiolipins in CM. A redistribution of cardiolipin in CM was found (<xref rid="fig8" ref-type="fig">Figure 8</xref>). In <italic>E. faecalis</italic> ATCC 29212 (<xref rid="fig8" ref-type="fig">Figures 8A</xref>,<xref rid="fig8" ref-type="fig">D</xref>) and EFDO-<italic>cls</italic> (<xref rid="fig8" ref-type="fig">Figures 8B</xref>,<xref rid="fig8" ref-type="fig">E</xref>), the cardiolipin-rich regions were mainly located at the cell septum or at both poles, while in the <italic>cls</italic>-mutant strain EF332-<italic>cls</italic>, the cardiolipin-rich regions were scattered all over the cell, leading to a more even distribution and reduced abundance at septa (<xref rid="fig8" ref-type="fig">Figures 8C</xref>,<xref rid="fig8" ref-type="fig">F</xref>). This is in agreement with previous suggestion that daptomycin resistance may be resulted from redistribution of phospholipids and diverting DAP from effective targets at the septum (<xref ref-type="bibr" rid="ref24">Heidary et al., 2018</xref>).</p>
<fig position="float" id="fig8">
<label>Figure 8</label>
<caption><p>Cardiolipin redistribution caused by <italic>cls</italic> mutations. Panels <bold>(A,D)</bold> <italic>Enterococcus faecalis</italic> ATCC 29212; Panels <bold>(B,E)</bold> EFDO-<italic>cls</italic>; Panels <bold>(C,F)</bold> EF332-<italic>cls.</italic></p></caption>
<graphic xlink:href="fmicb-13-896916-g008.tif"/>
</fig>
</sec>
<sec id="sec21">
<title>Structure Predictions Suggest That Cls Mutations May Affect Phospholipase Activity</title>
<p>Pfam was used to predict Cls domain structures, leading to the finding that the identified I269T mutation in this work is located in one of phospholipase D-like domains (<xref rid="fig9" ref-type="fig">Figure 9</xref>). As a three-dimensional structure of Cls is not available, we predicted its three-dimensional structure by AlphaFold 2 (<xref rid="fig10" ref-type="fig">Figure 10</xref>). Interestingly, T269 of the Cls mutant is located at the bottom of a pocket that could potentially bind substrate for catalysis (<xref rid="fig10" ref-type="fig">Figure 10B</xref>). This is in agreement with domain structure binding, which leads to the suggestion that mutations of Cls may affect the phospholipase activity of this cardiolipin synthase.</p>
<fig position="float" id="fig9">
<label>Figure 9</label>
<caption><p>Domain structure prediction of Cls with Pfam.</p></caption>
<graphic xlink:href="fmicb-13-896916-g009.tif"/>
</fig>
<fig position="float" id="fig10">
<label>Figure 10</label>
<caption><p>Three-dimensional structure prediction of Cls I269T mutant. Panel <bold>(A)</bold>, cartoon presentation; Panel <bold>(B)</bold>, surface presentation. Red color indicates T269 residue.</p></caption>
<graphic xlink:href="fmicb-13-896916-g010.tif"/>
</fig>
</sec>
<sec id="sec22">
<title>Mutations in <italic>cls</italic> Did Not Lead to Changes in Cell Ultrastructure</title>
<p>Using transmission electron microscopy, we were able to compare whether <italic>cls</italic> mutations caused changes in cell envelope and septa between <italic>cls</italic> mutant and parent strains. As shown in <xref rid="fig11" ref-type="fig">Figure 11</xref>, for parent strain <italic>E. faecalis</italic> ATCC 29212 and mutant strain EF332-<italic>cls</italic>, the cell surfaces and septum of both strains were smooth, and both single-septum (red arrows) and multiple-septum morphology (blue arrows) were observed and their morphology were similar. This result suggests that <italic>cls</italic> mutations does not change the structure of cell envelope.</p>
<fig position="float" id="fig11">
<label>Figure 11</label>
<caption><p>Ultrastructure of <italic>cls</italic> parent and mutant strains. Panels <bold>(A&#x2013;D)</bold> <italic>Enterococcus faecalis</italic> ATCC 29212; Panels <bold>(E&#x2013;H)</bold> EF332-<italic>cls</italic>. Image magnifications for Panels <bold>(A,E)</bold>, Panels <bold>(B,F)</bold>, Panels <bold>(C,G)</bold>, and Panels <bold>(D,H)</bold> are 5,000, 20,000, 50,000, and 50,000, respectively. The red arrow marks a single-septum structure, and the blue arrow marks multiple-septum structures.</p></caption>
<graphic xlink:href="fmicb-13-896916-g011.tif"/>
</fig>
</sec>
</sec>
<sec id="sec23" sec-type="discussions">
<title>Discussion</title>
<p>As VRE has spread extensively and treatment options have become increasingly limited, DAP is considered to be one of last resort antibiotics for VRE. Assessing DAP resistance, particularly in a vancomycin-resistant strain, is therefore of particular interest. In this work, a DAP-resistant VRE (<italic>E. faecium</italic> EF332) was identified and investigated to understand its mechanism for DAP resistance. Based on whole-genome sequencing and genome comparison, new mutations of two genes associated with phospholipid metabolism, <italic>cls</italic> and <italic>gdpD</italic>, were identified and suspected to be involved in DAP resistance. Mutations in the two genes were shown to be necessary for DAP resistance in previous studies (<xref ref-type="bibr" rid="ref3">Arias et al., 2011</xref>). Therefore, investigations of the identified new mutations were carried out to verify their relationship with DAP resistance.</p>
<p>Results of this work suggest that mutations in <italic>cls</italic> alone can confer DAP resistance. The c<italic>ls</italic> gene encodes a cardiolipin synthase, which catalyzes the production of cardiolipin from two molecules of phosphatidylglycerol. Previous studies have suggested that an increase in the concentration of cardiolipin in CM can divert more DAP from its target septum to other sites, thereby improving DAP resistance (<xref ref-type="bibr" rid="ref65">Zhang et al., 2014</xref>; <xref ref-type="bibr" rid="ref60">Tran et al., 2015</xref>). Some bacteria can change the membrane anionic microdomain to resist DAP by reducing the negatively charged membrane phospholipid composition (<xref ref-type="bibr" rid="ref43">Mishra et al., 2017</xref>). While analysis of phospholipid composition by 2D-TLC showed that the <italic>cls</italic> mutations did not change the phospholipid composition of CM (including cardiolipin levels; <xref rid="fig6" ref-type="fig">Figure 6</xref>), the <italic>cls</italic> mutations led to decrease in negative charges on the cell surface (<xref rid="fig7" ref-type="fig">Figure 7</xref>) and may lead to a reduced adhesion to DAP. It has been reported that membrane lipids are asymmetrically distributed in the inner and outer leaflet of CM (<xref ref-type="bibr" rid="ref59">Tannert et al., 2003</xref>). We therefore postulated that <italic>cls</italic> mutations do not change the level of cardiolipin synthesized but change the distribution of cardiolipin in CM, leading to reduction of cardiolipin in the outer leaflet of CM, thereby reducing membrane surface negative charges and the adhesion of DAP (<xref ref-type="bibr" rid="ref45">Mukhopadhyay et al., 2007</xref>). It was previously suggested that DAP resistance can also be caused by redistribution of anionic phospholipids and diverting from effective targets at the septum (<xref ref-type="bibr" rid="ref62">Tran et al., 2013b</xref>; <xref ref-type="bibr" rid="ref24">Heidary et al., 2018</xref>). In this work, mutations of <italic>cls</italic> led to a more evenly distributed cardiolipins and reduction in septa (<xref rid="fig8" ref-type="fig">Figure 8C</xref>), in agreement with this theory. Therefore, we suspect the resistance to DAP found in this work is also attributable to the redistribution of cardiolipin away from the cell septa. Both events, reduction of cellular negative charge and redistribution of phospholipids, may work together or even synergistically to complete the development of DAP resistance in <italic>E. faecium</italic>. We also found that <italic>cls</italic> mutations did not lead to changes in cell ultrastructure, which is inconsistent with the previously reported results observed in S613 (DAP susceptible) and R712 (DAP-resistant, deletion of Lys at position 61) strains (<xref ref-type="bibr" rid="ref3">Arias et al., 2011</xref>). This may be due to different effects of different mutated sites on the cell envelope and septum.</p>
<p>Out of the three mutations in <italic>cls</italic>, both I203V and S298T are mutations to similar amino acids, while I269T is a mutation from hydrophobic residue to polar residue. We therefore speculate that I269T is the effective mutation conferring DAP resistance. This is further supported by predictions of domain structure (<xref rid="fig9" ref-type="fig">Figure 9</xref>) and three-dimensional structure (<xref rid="fig10" ref-type="fig">Figure 10</xref>), which suggests that I269T mutation may alter the catalytic activity of cardiolipin synthase. Another DAP-resistant strain of <italic>E. faecium</italic> found by our research team also showed the same I269T mutation (data not shown), which also supports our prediction.</p>
<p>Although the MIC of DAP on <italic>E. faecium</italic> EF332 is not high (8&#x2009;&#x03BC;g/ml), it has a high potential transmission risk. MLST analysis revealed that the sequence type of <italic>E. faecium</italic> EF332 is ST192, belonging to epidemic hospital strains (clade A1), which included polyclonal complex 17 (CC17; <xref ref-type="bibr" rid="ref37">Lebreton et al., 2013</xref>, <xref ref-type="bibr" rid="ref36">2018</xref>). <italic>Enterococcus faecium</italic> of CC17 is high-risk clonal lineages, which is often associated with nosocomial VRE outbreak and leads to severe morbidity and mortality (<xref ref-type="bibr" rid="ref38">Lee et al., 2019</xref>). Worryingly, plasmid pEF332-2 in this study carried two high-risk gene clusters <italic>vanA</italic> and <italic>vanM</italic>. <italic>VanA</italic> gene clusters were also found on genomic islands GIs011 and prophage (<xref rid="fig1" ref-type="fig">Figure 1</xref>). This means that vancomycin resistance of this strain could easily disseminate, leading to higher levels of prevalence. One more thing to note is <italic>vanM</italic> gene has only been previously reported in Shanghai, Chengdu, Hangzhou, and Beijing in China (<xref ref-type="bibr" rid="ref12">Chen et al., 2014</xref>, <xref ref-type="bibr" rid="ref11">2015</xref>; <xref ref-type="bibr" rid="ref56">Sun et al., 2019a</xref>,<xref ref-type="bibr" rid="ref57">b</xref>). <italic>Enterococcus faecium</italic> EF332 carrying <italic>vanM</italic> genes in this study was found in Jinan of China, suggesting that <italic>vanM</italic> gene may have already spread nationwide.</p>
</sec>
<sec id="sec24" sec-type="conclusions">
<title>Conclusion</title>
<p>In this study, a clinical DAP-resistant VRE was identified. Whole-genome sequencing revealed the genetic background for multidrug resistance. A new plasmid pEF332-2 was found to carry two vancomycin resistance clusters, a rare phenomenon reported only twice so far. The genetic basis for daptomycin was investigated, suggesting new mutations in <italic>cls</italic> gene confer DAP resistance. The mechanisms of DAP resistance were further investigated, showing that <italic>cls</italic> mutations lead to significant decrease of membrane surface negative charges and the redistribution of cardiolipin in CM, both of which contribute to DAP resistance. This work reports the genetic basis of multidrug resistance of a daptomycin- and vancomycin-resistant <italic>E. faecium</italic>, and new mutations of <italic>cls</italic> that leads to resistance of daptomycin, a key last-resort antibiotic.</p>
</sec>
<sec id="sec25" sec-type="data-availability">
<title>Data Availability Statement</title>
<p>To fully understand the genetic basis of multidrug resistance in E. faecium EF332, whole-genome sequences were obtained with third-generation PacBio sequencing accompanied by second-generation Illumina sequencing (The sequencing data were deposited in GenBank with accession numbers CP058891-CP058895).</p>
</sec>
<sec id="sec26">
<title>Author Contributions</title>
<p>HX and MW designed this study and revised the manuscript. XZ was responsible for sample collection and strain identification and participated in experimental design. HS helped to analyze membrane lipid compositions. JH, LL, MZ, QC, and YM participated in the experiments and assisted in collecting experimental data. WL performed experiments, collected and analyzed the data, and wrote the draft of the manuscript. All authors contributed to the article and approved the submitted version.</p>
</sec>
<sec id="sec27" sec-type="funding-information">
<title>Funding</title>
<p>This work was supported by the National Key Research and Development Program of China (grant number 2021YFE0199800), Key R&#x0026;D Program of Shandong Province (grant number 2020CXGC011305); the National Natural Science Foundation of China (Grant numbers 31770042 and 31770043); and Shandong Provincial Natural Science Foundation (grant number ZR2020MH308).</p>
</sec>
<sec id="conf1" sec-type="COI-statement">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="sec30" sec-type="disclaimer">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</body>
<back>
<ack>
<p>We thank Sen Wang, Haiyan Yu, and Yuyu Guo of the Core Facilities for Life and Environmental Sciences, State Key Laboratory of Microbial Technology of Shandong University for focused ion beam-scanning transmission electron microscope, inverted fluorescence microscope, and laser scanning confocal microscope analysis. We also thank Jingyi Zhu from State Key Laboratory of Microbial Technology of Shandong University for protein structure prediction.</p>
</ack>
<sec id="sec29" sec-type="supplementary-material">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link xlink:href="https://www.frontiersin.org/articles/10.3389/fmicb.2022.896916/full#supplementary-material" ext-link-type="uri">https://www.frontiersin.org/articles/10.3389/fmicb.2022.896916/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Table_1.xlsx" id="SM1" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table_2.XLSX" id="SM2" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Data_Sheet_1.docx" id="SM3" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Image_1.TIF" id="SM4" mimetype="image/tiff" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="ref1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ardui</surname> <given-names>S.</given-names></name> <name><surname>Ameur</surname> <given-names>A.</given-names></name> <name><surname>Vermeesch</surname> <given-names>J. R.</given-names></name> <name><surname>Hestand</surname> <given-names>M. S.</given-names></name></person-group> (<year>2018</year>). <article-title>Single molecule real-time (SMRT) sequencing comes of age: applications and utilities for medical diagnostics</article-title>. <source>Nucleic Acids Res.</source> <volume>46</volume>, <fpage>2159</fpage>&#x2013;<lpage>2168</lpage>. doi: <pub-id pub-id-type="doi">10.1093/nar/gky066</pub-id>, PMID: <pub-id pub-id-type="pmid">29401301</pub-id></citation></ref>
<ref id="ref2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Arias</surname> <given-names>C. A.</given-names></name> <name><surname>Murray</surname> <given-names>B. E.</given-names></name></person-group> (<year>2012</year>). <article-title>The rise of the <italic>Enterococcus</italic>: beyond vancomycin resistance</article-title>. <source>Nat. Rev. Microbiol.</source> <volume>10</volume>, <fpage>266</fpage>&#x2013;<lpage>278</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nrmicro2761</pub-id>, PMID: <pub-id pub-id-type="pmid">22421879</pub-id></citation></ref>
<ref id="ref3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Arias</surname> <given-names>C. A.</given-names></name> <name><surname>Panesso</surname> <given-names>D.</given-names></name> <name><surname>McGrath</surname> <given-names>D. M.</given-names></name> <name><surname>Qin</surname> <given-names>X.</given-names></name> <name><surname>Mojica</surname> <given-names>M. F.</given-names></name> <name><surname>Miller</surname> <given-names>C.</given-names></name> <etal/></person-group>. (<year>2011</year>). <article-title>Genetic basis for <italic>in vivo</italic> daptomycin resistance in enterococci</article-title>. <source>N. Engl. J. Med.</source> <volume>365</volume>, <fpage>892</fpage>&#x2013;<lpage>900</lpage>. doi: <pub-id pub-id-type="doi">10.1056/NEJMoa1011138.Genetic</pub-id>, PMID: <pub-id pub-id-type="pmid">21899450</pub-id></citation></ref>
<ref id="ref4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Arndt</surname> <given-names>D.</given-names></name> <name><surname>Grant</surname> <given-names>J. R.</given-names></name> <name><surname>Marcu</surname> <given-names>A.</given-names></name> <name><surname>Sajed</surname> <given-names>T.</given-names></name> <name><surname>Pon</surname> <given-names>A.</given-names></name> <name><surname>Liang</surname> <given-names>Y.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>PHASTER: a better, faster version of the PHAST phage search tool</article-title>. <source>Nucleic Acids Res.</source> <volume>44</volume>, <fpage>W16</fpage>&#x2013;<lpage>W21</lpage>. doi: <pub-id pub-id-type="doi">10.1093/nar/gkw387</pub-id>, PMID: <pub-id pub-id-type="pmid">27141966</pub-id></citation></ref>
<ref id="ref5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ashburner</surname> <given-names>M.</given-names></name> <name><surname>Ball</surname> <given-names>C. A.</given-names></name> <name><surname>Blake</surname> <given-names>J. A.</given-names></name> <name><surname>Botstein</surname> <given-names>D.</given-names></name> <name><surname>Butler</surname> <given-names>H.</given-names></name> <name><surname>Cherry</surname> <given-names>J. M.</given-names></name> <etal/></person-group>. (<year>2000</year>). <article-title>Gene ontology: tool for the unification of biology</article-title>. <source>Nat. Genet.</source> <volume>25</volume>, <fpage>25</fpage>&#x2013;<lpage>29</lpage>. doi: <pub-id pub-id-type="doi">10.1038/75556</pub-id>, PMID: <pub-id pub-id-type="pmid">10802651</pub-id></citation></ref>
<ref id="ref6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bairoch</surname> <given-names>A.</given-names></name> <name><surname>Apweiler</surname> <given-names>R.</given-names></name></person-group> (<year>2000</year>). <article-title>The SWISS-PROT protein sequence database and its supplement TrEMBL in 2000</article-title>. <source>Nucleic Acids Res.</source> <volume>28</volume>, <fpage>45</fpage>&#x2013;<lpage>48</lpage>. doi: <pub-id pub-id-type="doi">10.1128/AAC.02435-16</pub-id>, PMID: <pub-id pub-id-type="pmid">10592178</pub-id></citation></ref>
<ref id="ref7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bender</surname> <given-names>J. K.</given-names></name> <name><surname>Cattoir</surname> <given-names>V.</given-names></name> <name><surname>Hegstad</surname> <given-names>K.</given-names></name> <name><surname>Sadowy</surname> <given-names>E.</given-names></name> <name><surname>Coque</surname> <given-names>T. M.</given-names></name> <name><surname>Westh</surname> <given-names>H.</given-names></name> <etal/></person-group>. (<year>2018</year>). <article-title>Update on prevalence and mechanisms of resistance to linezolid, tigecycline and daptomycin in enterococci in Europe: towards a common nomenclature</article-title>. <source>Drug Resist. Updat.</source> <volume>40</volume>, <fpage>25</fpage>&#x2013;<lpage>39</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.drup.2018.10.002</pub-id>, PMID: <pub-id pub-id-type="pmid">30447411</pub-id></citation></ref>
<ref id="ref8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Besemer</surname> <given-names>J.</given-names></name> <name><surname>Lomsadze</surname> <given-names>A.</given-names></name> <name><surname>Borodovsky</surname> <given-names>M.</given-names></name></person-group> (<year>2001</year>). <article-title>GeneMarkS: a self-training method for prediction of gene starts in microbial genomes. Implications for finding sequence motifs in regulatory regions</article-title>. <source>Nucleic Acids Res.</source> <volume>29</volume>, <fpage>2607</fpage>&#x2013;<lpage>2618</lpage>. doi: <pub-id pub-id-type="doi">10.1093/nar/29.12.2607</pub-id>, PMID: <pub-id pub-id-type="pmid">11410670</pub-id></citation></ref>
<ref id="ref9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Carver</surname> <given-names>P. L.</given-names></name> <name><surname>Whang</surname> <given-names>E.</given-names></name> <name><surname>VandenBussche</surname> <given-names>H. L.</given-names></name> <name><surname>Kauffman</surname> <given-names>C. A.</given-names></name> <name><surname>Malani</surname> <given-names>P. N.</given-names></name></person-group> (<year>2003</year>). <article-title>Risk factors for arthralgias or myalgias associated with quinupristin-dalfopristin therapy</article-title>. <source>Pharmacotherapy</source> <volume>23</volume>, <fpage>159</fpage>&#x2013;<lpage>164</lpage>. doi: <pub-id pub-id-type="doi">10.1592/phco.23.2.159.32078</pub-id></citation></ref>
<ref id="ref10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cattoir</surname> <given-names>V.</given-names></name> <name><surname>Giard</surname> <given-names>J. C.</given-names></name></person-group> (<year>2014</year>). <article-title>Antibiotic resistance in <italic>Enterococcus faecium</italic> clinical isolates</article-title>. <source>Expert Rev. Anti-Infect. Ther.</source> <volume>12</volume>, <fpage>239</fpage>&#x2013;<lpage>248</lpage>. doi: <pub-id pub-id-type="doi">10.1586/14787210.2014.870886</pub-id></citation></ref>
<ref id="ref11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>C.</given-names></name> <name><surname>Sun</surname> <given-names>J.</given-names></name> <name><surname>Guo</surname> <given-names>Y.</given-names></name> <name><surname>Lin</surname> <given-names>D.</given-names></name> <name><surname>Guo</surname> <given-names>Q.</given-names></name> <name><surname>Hu</surname> <given-names>F.</given-names></name> <etal/></person-group>. (<year>2015</year>). <article-title>High prevalence of <italic>vanM</italic> in vancomycin-resistant <italic>Enterococcus faecium</italic> isolates from Shanghai, China</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>59</volume>, <fpage>7795</fpage>&#x2013;<lpage>7798</lpage>. doi: <pub-id pub-id-type="doi">10.1128/AAC.01732-15</pub-id>, PMID: <pub-id pub-id-type="pmid">26369966</pub-id></citation></ref>
<ref id="ref12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>C.</given-names></name> <name><surname>Xu</surname> <given-names>X.</given-names></name> <name><surname>Qu</surname> <given-names>T.</given-names></name> <name><surname>Yu</surname> <given-names>Y.</given-names></name> <name><surname>Ying</surname> <given-names>C.</given-names></name> <name><surname>Liu</surname> <given-names>Q.</given-names></name> <etal/></person-group>. (<year>2014</year>). <article-title>Prevalence of the fosfomycin-resistance determinant, <italic>fosB3</italic>, in <italic>Enterococcus faecium</italic> clinical isolates from China</article-title>. <source>J. Med. Microbiol.</source> <volume>63</volume>, <fpage>1484</fpage>&#x2013;<lpage>1489</lpage>. doi: <pub-id pub-id-type="doi">10.1099/jmm.0.077701-0</pub-id>, PMID: <pub-id pub-id-type="pmid">25102907</pub-id></citation></ref>
<ref id="ref13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chow</surname> <given-names>A.</given-names></name> <name><surname>Win</surname> <given-names>N. N.</given-names></name> <name><surname>Ng</surname> <given-names>P. Y.</given-names></name> <name><surname>Lee</surname> <given-names>W.</given-names></name> <name><surname>Win</surname> <given-names>M. K.</given-names></name></person-group> (<year>2016</year>). <article-title>Vancomycin-resistant enterococci with reduced daptomycin susceptibility in Singapore: prevalence and associated factors</article-title>. <source>Epidemiol. Infect.</source> <volume>144</volume>, <fpage>2540</fpage>&#x2013;<lpage>2545</lpage>. doi: <pub-id pub-id-type="doi">10.1017/S0950268816000923</pub-id>, PMID: <pub-id pub-id-type="pmid">27174845</pub-id></citation></ref>
<ref id="ref14"><citation citation-type="journal"><person-group person-group-type="author"><collab id="coll1">CLSI</collab></person-group> (<year>2018</year>). <article-title>Performance standards for antimicrobial susceptibility testing</article-title>. <source>Clin. Lab. Stand. Inst.</source> <fpage>1</fpage>&#x2013;<lpage>296</lpage>.</citation></ref>
<ref id="ref15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Davlieva</surname> <given-names>M.</given-names></name> <name><surname>Zhang</surname> <given-names>W.</given-names></name> <name><surname>Arias</surname> <given-names>C. A.</given-names></name> <name><surname>Shamoo</surname> <given-names>Y.</given-names></name></person-group> (<year>2013</year>). <article-title>Biochemical characterization of cardiolipin synthase mutations associated with daptomycin resistance in enterococci</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>57</volume>, <fpage>289</fpage>&#x2013;<lpage>296</lpage>. doi: <pub-id pub-id-type="doi">10.1128/AAC.01743-12</pub-id>, PMID: <pub-id pub-id-type="pmid">23114777</pub-id></citation></ref>
<ref id="ref16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Depardieu</surname> <given-names>F.</given-names></name> <name><surname>Podglajen</surname> <given-names>I.</given-names></name> <name><surname>Leclercq</surname> <given-names>R.</given-names></name> <name><surname>Collatz</surname> <given-names>E.</given-names></name> <name><surname>Courvalin</surname> <given-names>P.</given-names></name></person-group> (<year>2007</year>). <article-title>Modes and modulations of antibiotic resistance gene expression</article-title>. <source>Clin. Microbiol. Rev.</source> <volume>20</volume>, <fpage>79</fpage>&#x2013;<lpage>114</lpage>. doi: <pub-id pub-id-type="doi">10.1128/CMR.00015-06</pub-id>, PMID: <pub-id pub-id-type="pmid">17223624</pub-id></citation></ref>
<ref id="ref17"><citation citation-type="journal"><person-group person-group-type="author"><collab id="coll2">EUCAST</collab></person-group> (<year>2017</year>). <article-title>The European committee on antimicrobial susceptibility testing</article-title>. <source>Eur. Comm. Antimicrob. Susceptibility Test</source> <fpage>1</fpage>&#x2013;<lpage>146</lpage>.</citation></ref>
<ref id="ref18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fischer</surname> <given-names>A.</given-names></name> <name><surname>Yang</surname> <given-names>S. J.</given-names></name> <name><surname>Bayer</surname> <given-names>A. S.</given-names></name> <name><surname>Vaezzadeh</surname> <given-names>A. R.</given-names></name> <name><surname>Herzig</surname> <given-names>S.</given-names></name> <name><surname>Stenz</surname> <given-names>L.</given-names></name> <etal/></person-group>. (<year>2011</year>). <article-title>Daptomycin resistance mechanisms in clinically derived <italic>Staphylococcus aureus</italic> strains assessed by a combined transcriptomics and proteomics approach</article-title>. <source>J. Antimicrob. Chemother.</source> <volume>66</volume>, <fpage>1696</fpage>&#x2013;<lpage>1711</lpage>. doi: <pub-id pub-id-type="doi">10.1093/jac/dkr195</pub-id>, PMID: <pub-id pub-id-type="pmid">21622973</pub-id></citation></ref>
<ref id="ref19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Freitas</surname> <given-names>A. R.</given-names></name> <name><surname>Tedim</surname> <given-names>A. P.</given-names></name> <name><surname>Novais</surname> <given-names>C.</given-names></name> <name><surname>Ruiz-Garbajosa</surname> <given-names>P.</given-names></name> <name><surname>Werner</surname> <given-names>G.</given-names></name> <name><surname>Laverde-Gomez</surname> <given-names>J. A.</given-names></name> <etal/></person-group>. (<year>2010</year>). <article-title>Global spread of the hylEfm colonization-virulence gene in megaplasmids of the <italic>Enterococcus faecium</italic> CC17 polyclonal subcluster</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>54</volume>, <fpage>2660</fpage>&#x2013;<lpage>2665</lpage>. doi: <pub-id pub-id-type="doi">10.1128/AAC.00134-10</pub-id>, PMID: <pub-id pub-id-type="pmid">20385861</pub-id></citation></ref>
<ref id="ref20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Galperin</surname> <given-names>M. Y.</given-names></name> <name><surname>Makarova</surname> <given-names>K. S.</given-names></name> <name><surname>Wolf</surname> <given-names>Y. I.</given-names></name> <name><surname>Koonin</surname> <given-names>E. V.</given-names></name></person-group> (<year>2014</year>). <article-title>Expanded microbial genome coverage and improved protein family annotation in the COG database</article-title>. <source>Nucleic Acids Res.</source> <volume>43</volume>, <fpage>D261</fpage>&#x2013;<lpage>D269</lpage>. doi: <pub-id pub-id-type="doi">10.1093/nar/gku1223</pub-id>, PMID: <pub-id pub-id-type="pmid">25428365</pub-id></citation></ref>
<ref id="ref21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gonzalez-Ruiz</surname> <given-names>A.</given-names></name> <name><surname>Seaton</surname> <given-names>R. A.</given-names></name> <name><surname>Hamed</surname> <given-names>K.</given-names></name></person-group> (<year>2016</year>). <article-title>Daptomycin: an evidence-based review of its role in the treatment of gram-positive infections</article-title>. <source>Infect. Drug Resist.</source> <volume>9</volume>, <fpage>47</fpage>&#x2013;<lpage>58</lpage>. doi: <pub-id pub-id-type="doi">10.2147/IDR.S99046</pub-id>, PMID: <pub-id pub-id-type="pmid">27143941</pub-id></citation></ref>
<ref id="ref22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Grein</surname> <given-names>F.</given-names></name> <name><surname>M&#x00FC;ller</surname> <given-names>A.</given-names></name> <name><surname>Scherer</surname> <given-names>K. M.</given-names></name> <name><surname>Liu</surname> <given-names>X.</given-names></name> <name><surname>Ludwig</surname> <given-names>K. C.</given-names></name> <name><surname>Kl&#x00F6;ckner</surname> <given-names>A.</given-names></name> <etal/></person-group>. (<year>2020</year>). <article-title>Ca<sup>2+</sup>-Daptomycin targets cell wall biosynthesis by forming a tripartite complex with undecaprenyl-coupled intermediates and membrane lipids</article-title>. <source>Nat. Commun.</source> <volume>11</volume>:<fpage>1455</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41467-020-15257-1</pub-id>, PMID: <pub-id pub-id-type="pmid">32193379</pub-id></citation></ref>
<ref id="ref23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hashimoto</surname> <given-names>Y.</given-names></name> <name><surname>Taniguchi</surname> <given-names>M.</given-names></name> <name><surname>Uesaka</surname> <given-names>K.</given-names></name> <name><surname>Nomura</surname> <given-names>T.</given-names></name> <name><surname>Hirakawa</surname> <given-names>H.</given-names></name> <name><surname>Tanimoto</surname> <given-names>K.</given-names></name> <etal/></person-group>. (<year>2019</year>). <article-title>Novel multidrug-resistant enterococcal mobile linear plasmid pELF1 encoding <italic>vanA</italic> and <italic>vanM</italic> gene clusters from a Japanese vancomycin-resistant enterococci isolate</article-title>. <source>Front. Microbiol.</source> <volume>10</volume>:<fpage>2568</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fmicb.2019.02568</pub-id>, PMID: <pub-id pub-id-type="pmid">31798546</pub-id></citation></ref>
<ref id="ref24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Heidary</surname> <given-names>M.</given-names></name> <name><surname>Khosravi</surname> <given-names>A. D.</given-names></name> <name><surname>Khoshnood</surname> <given-names>S.</given-names></name> <name><surname>Nasiri</surname> <given-names>M. J.</given-names></name> <name><surname>Soleimani</surname> <given-names>S.</given-names></name> <name><surname>Goudarzi</surname> <given-names>M.</given-names></name></person-group> (<year>2018</year>). <article-title>Daptomycin</article-title>. <source>J. Antimicrob. Chemother.</source> <volume>73</volume>, <fpage>1</fpage>&#x2013;<lpage>11</lpage>. doi: <pub-id pub-id-type="doi">10.1093/jac/dkx349</pub-id></citation></ref>
<ref id="ref25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Herc</surname> <given-names>E. S.</given-names></name> <name><surname>Kauffman</surname> <given-names>C. A.</given-names></name> <name><surname>Marini</surname> <given-names>B. L.</given-names></name> <name><surname>Perissinotti</surname> <given-names>A. J.</given-names></name> <name><surname>Miceli</surname> <given-names>M. H.</given-names></name></person-group> (<year>2017</year>). <article-title>Daptomycin nonsusceptible vancomycin resistant <italic>Enterococcus</italic> bloodstream infections in patients with hematological malignancies: risk factors and outcomes</article-title>. <source>Leuk. Lymphoma</source> <volume>58</volume>, <fpage>2852</fpage>&#x2013;<lpage>2858</lpage>. doi: <pub-id pub-id-type="doi">10.1080/10428194.2017.1312665</pub-id>, PMID: <pub-id pub-id-type="pmid">28402152</pub-id></citation></ref>
<ref id="ref26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ho</surname> <given-names>S. N.</given-names></name> <name><surname>Hunt</surname> <given-names>H. D.</given-names></name> <name><surname>Horton</surname> <given-names>R. M.</given-names></name> <name><surname>Pullen</surname> <given-names>J. K.</given-names></name> <name><surname>Pease</surname> <given-names>L. R.</given-names></name></person-group> (<year>1989</year>). <article-title>Site-directed mutagenesis by overlap extension using the polymerase chain reaction</article-title>. <source>Gene</source> <volume>77</volume>, <fpage>51</fpage>&#x2013;<lpage>59</lpage>. doi: <pub-id pub-id-type="doi">10.1016/0378-1119(89)90358-2</pub-id></citation></ref>
<ref id="ref27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hogan</surname> <given-names>H. L.</given-names></name> <name><surname>Hachem</surname> <given-names>R. Y.</given-names></name> <name><surname>Neuhauser</surname> <given-names>M.</given-names></name> <name><surname>Raad</surname> <given-names>I. I.</given-names></name> <name><surname>Coyle</surname> <given-names>E.</given-names></name></person-group> (<year>2010</year>). <article-title>Clinical experience of linezolid in bone marrow transplantation patients</article-title>. <source>J. Pharm. Pract.</source> <volume>23</volume>, <fpage>352</fpage>&#x2013;<lpage>357</lpage>. doi: <pub-id pub-id-type="doi">10.1177/0897190009358773</pub-id>, PMID: <pub-id pub-id-type="pmid">21507835</pub-id></citation></ref>
<ref id="ref28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hsiao</surname> <given-names>W.</given-names></name> <name><surname>Wan</surname> <given-names>I.</given-names></name> <name><surname>Jones</surname> <given-names>S. J.</given-names></name> <name><surname>Brinkman</surname> <given-names>F. S. L.</given-names></name></person-group> (<year>2003</year>). <article-title>IslandPath: aiding detection of genomic islands in prokaryotes</article-title>. <source>Bioinformatics</source> <volume>19</volume>, <fpage>418</fpage>&#x2013;<lpage>420</lpage>. doi: <pub-id pub-id-type="doi">10.1093/bioinformatics/btg004</pub-id>, PMID: <pub-id pub-id-type="pmid">12584130</pub-id></citation></ref>
<ref id="ref29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Humphries</surname> <given-names>R. M.</given-names></name> <name><surname>Kelesidis</surname> <given-names>T.</given-names></name> <name><surname>Tewhey</surname> <given-names>R.</given-names></name> <name><surname>Rose</surname> <given-names>W. E.</given-names></name> <name><surname>Schork</surname> <given-names>N.</given-names></name> <name><surname>Nizet</surname> <given-names>V.</given-names></name> <etal/></person-group>. (<year>2012</year>). <article-title>Genotypic and phenotypic evaluation of the evolution of high-level daptomycin nonsusceptibility in vancomycin-resistant <italic>Enterococcus faecium</italic></article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>56</volume>, <fpage>6051</fpage>&#x2013;<lpage>6053</lpage>. doi: <pub-id pub-id-type="doi">10.1128/AAC.01318-12</pub-id>, PMID: <pub-id pub-id-type="pmid">22948885</pub-id></citation></ref>
<ref id="ref30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hussain</surname> <given-names>K.</given-names></name> <name><surname>Ullah</surname> <given-names>S.</given-names></name> <name><surname>Tahir</surname> <given-names>H.</given-names></name> <name><surname>Alkilani</surname> <given-names>W. Z.</given-names></name> <name><surname>Naeem</surname> <given-names>M.</given-names></name> <name><surname>Vinod</surname> <given-names>N. R.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>Daptomycin- vancomycin-resistant <italic>Enterococcus faecium</italic> native valve endocarditis: successfully treated with off-label quinupristin-dalfopristin</article-title>. <source>J. Investig. Med. High Impact Case Rep.</source> <volume>4</volume>, <fpage>3</fpage>&#x2013;<lpage>5</lpage>. doi: <pub-id pub-id-type="doi">10.1177/2324709616665408</pub-id>, PMID: <pub-id pub-id-type="pmid">27689100</pub-id></citation></ref>
<ref id="ref31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jia</surname> <given-names>B.</given-names></name> <name><surname>Raphenya</surname> <given-names>A. R.</given-names></name> <name><surname>Alcock</surname> <given-names>B.</given-names></name> <name><surname>Waglechner</surname> <given-names>N.</given-names></name> <name><surname>Guo</surname> <given-names>P.</given-names></name> <name><surname>Tsang</surname> <given-names>K. K.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>CARD 2017: expansion and model-centric curation of the comprehensive antibiotic resistance database</article-title>. <source>Nucleic Acids Res.</source> <volume>45</volume>, <fpage>D566</fpage>&#x2013;<lpage>D573</lpage>. doi: <pub-id pub-id-type="doi">10.1093/nar/gkw1004</pub-id>, PMID: <pub-id pub-id-type="pmid">27789705</pub-id></citation></ref>
<ref id="ref32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jumper</surname> <given-names>J.</given-names></name> <name><surname>Evans</surname> <given-names>R.</given-names></name> <name><surname>Pritzel</surname> <given-names>A.</given-names></name> <name><surname>Green</surname> <given-names>T.</given-names></name> <name><surname>Figurnov</surname> <given-names>M.</given-names></name> <name><surname>Ronneberger</surname> <given-names>O.</given-names></name> <etal/></person-group>. (<year>2021</year>). <article-title>Highly accurate protein structure prediction with AlphaFold</article-title>. <source>Nature</source> <volume>596</volume>, <fpage>583</fpage>&#x2013;<lpage>589</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41586-021-03819-2</pub-id>, PMID: <pub-id pub-id-type="pmid">34265844</pub-id></citation></ref>
<ref id="ref33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kelesidis</surname> <given-names>T.</given-names></name> <name><surname>Tewhey</surname> <given-names>R.</given-names></name> <name><surname>Humphries</surname> <given-names>R. M.</given-names></name></person-group> (<year>2013</year>). <article-title>Evolution of high-level daptomycin resistance in <italic>Enterococcus faecium</italic> during daptomycin therapy is associated with limited mutations in the bacterial genome</article-title>. <source>J. Antimicrob. Chemother.</source> <volume>68</volume>, <fpage>1926</fpage>&#x2013;<lpage>1928</lpage>. doi: <pub-id pub-id-type="doi">10.1093/jac/dkt117</pub-id>, PMID: <pub-id pub-id-type="pmid">23580562</pub-id></citation></ref>
<ref id="ref34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Komagata</surname> <given-names>K.</given-names></name> <name><surname>Suzuki</surname> <given-names>K. I.</given-names></name></person-group> (<year>1988</year>). <article-title>4 lipid and cell-wall analysis in bacterial systematics</article-title>. <source>Methods Microbiol.</source> <volume>19</volume>, <fpage>161</fpage>&#x2013;<lpage>207</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0580-9517(08)70410-0</pub-id></citation></ref>
<ref id="ref35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>LaPlante</surname> <given-names>K. L.</given-names></name> <name><surname>Rybak</surname> <given-names>M. J.</given-names></name></person-group> (<year>2004</year>). <article-title>Daptomycin &#x2013; a novel antibiotic against gram-positive pathogens</article-title>. <source>Expert. Opin. Pharmacother.</source> <volume>5</volume>, <fpage>2321</fpage>&#x2013;<lpage>2331</lpage>. doi: <pub-id pub-id-type="doi">10.1517/14656566.5.11.2321</pub-id></citation></ref>
<ref id="ref36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lebreton</surname> <given-names>F.</given-names></name> <name><surname>Valentino</surname> <given-names>M. D.</given-names></name> <name><surname>Schaufler</surname> <given-names>K.</given-names></name> <name><surname>Earl</surname> <given-names>A. M.</given-names></name> <name><surname>Cattoir</surname> <given-names>V.</given-names></name> <name><surname>Gilmore</surname> <given-names>M. S.</given-names></name></person-group> (<year>2018</year>). <article-title>Transferable vancomycin resistance in clade B commensal-type <italic>Enterococcus faecium</italic></article-title>. <source>J. Antimicrob. Chemother.</source> <volume>73</volume>, <fpage>1479</fpage>&#x2013;<lpage>1486</lpage>. doi: <pub-id pub-id-type="doi">10.1093/jac/dky039</pub-id>, PMID: <pub-id pub-id-type="pmid">29462403</pub-id></citation></ref>
<ref id="ref37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lebreton</surname> <given-names>F.</given-names></name> <name><surname>van Schaik</surname> <given-names>W.</given-names></name> <name><surname>Manson McGuire</surname> <given-names>A.</given-names></name> <name><surname>Godfrey</surname> <given-names>P.</given-names></name> <name><surname>Griggs</surname> <given-names>A.</given-names></name> <name><surname>Mazumdar</surname> <given-names>V.</given-names></name> <etal/></person-group>. (<year>2013</year>). <article-title>Emergence of epidemic multidrug-resistant <italic>Enterococcus faecium</italic> from animal and commensal strains</article-title>. <source>MBio</source> <volume>4</volume>:<fpage>00534-13</fpage>. doi: <pub-id pub-id-type="doi">10.1128/mBio.00534-13</pub-id>, PMID: <pub-id pub-id-type="pmid">23963180</pub-id></citation></ref>
<ref id="ref38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>T.</given-names></name> <name><surname>Pang</surname> <given-names>S.</given-names></name> <name><surname>Abraham</surname> <given-names>S.</given-names></name> <name><surname>Coombs</surname> <given-names>G. W.</given-names></name></person-group> (<year>2019</year>). <article-title>Antimicrobial-resistant CC17 <italic>Enterococcus faecium</italic>: the past, the present and the future</article-title>. <source>J. Glob. Antimicrob. Resist.</source> <volume>16</volume>, <fpage>36</fpage>&#x2013;<lpage>47</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jgar.2018.08.016</pub-id>, PMID: <pub-id pub-id-type="pmid">30149193</pub-id></citation></ref>
<ref id="ref39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lellek</surname> <given-names>H.</given-names></name> <name><surname>Franke</surname> <given-names>G. C.</given-names></name> <name><surname>Ruckert</surname> <given-names>C.</given-names></name> <name><surname>Wolters</surname> <given-names>M.</given-names></name> <name><surname>Wolschke</surname> <given-names>C.</given-names></name> <name><surname>Christner</surname> <given-names>M.</given-names></name> <etal/></person-group>. (<year>2015</year>). <article-title>Emergence of daptomycin non-susceptibility in colonizing vancomycin-resistant <italic>Enterococcus faecium</italic> isolates during daptomycin therapy</article-title>. <source>Int. J. Med. Microbiol.</source> <volume>305</volume>, <fpage>902</fpage>&#x2013;<lpage>909</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ijmm.2015.09.005</pub-id>, PMID: <pub-id pub-id-type="pmid">26454536</pub-id></citation></ref>
<ref id="ref40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>W.</given-names></name> <name><surname>Jaroszewski</surname> <given-names>L.</given-names></name> <name><surname>Godzik</surname> <given-names>A.</given-names></name></person-group> (<year>2002</year>). <article-title>Tolerating some redundancy significantly speeds up clustering of large protein databases</article-title>. <source>Bioinformatics</source> <volume>18</volume>, <fpage>77</fpage>&#x2013;<lpage>82</lpage>. doi: <pub-id pub-id-type="doi">10.1093/bioinformatics/18.1.77</pub-id>, PMID: <pub-id pub-id-type="pmid">11836214</pub-id></citation></ref>
<ref id="ref41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Matsumoto</surname> <given-names>K.</given-names></name> <name><surname>Takeshita</surname> <given-names>A.</given-names></name> <name><surname>Ikawa</surname> <given-names>K.</given-names></name> <name><surname>Shigemi</surname> <given-names>A.</given-names></name> <name><surname>Yaji</surname> <given-names>K.</given-names></name> <name><surname>Shimodozono</surname> <given-names>Y.</given-names></name> <etal/></person-group>. (<year>2010</year>). <article-title>Higher linezolid exposure and higher frequency of thrombocytopenia in patients with renal dysfunction</article-title>. <source>Int. J. Antimicrob. Agents</source> <volume>36</volume>, <fpage>179</fpage>&#x2013;<lpage>181</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ijantimicag.2010.02.019</pub-id>, PMID: <pub-id pub-id-type="pmid">20392606</pub-id></citation></ref>
<ref id="ref42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mileykovskaya</surname> <given-names>E.</given-names></name> <name><surname>Dowhan</surname> <given-names>W.</given-names></name> <name><surname>Birke</surname> <given-names>R. L.</given-names></name> <name><surname>Zheng</surname> <given-names>D.</given-names></name> <name><surname>Lutterodt</surname> <given-names>L.</given-names></name> <name><surname>Haines</surname> <given-names>T. H.</given-names></name></person-group> (<year>2001</year>). <article-title>Cardiolipin binds nonyl acridine orange by aggregating the dye at exposed hydrophobic domains on bilayer surfaces</article-title>. <source>FEBS Lett.</source> <volume>507</volume>, <fpage>187</fpage>&#x2013;<lpage>190</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0014-5793(01)02948-9</pub-id>, PMID: <pub-id pub-id-type="pmid">11684095</pub-id></citation></ref>
<ref id="ref43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mishra</surname> <given-names>N. N.</given-names></name> <name><surname>Tran</surname> <given-names>T. T.</given-names></name> <name><surname>Seepersaud</surname> <given-names>R.</given-names></name> <name><surname>Garcia-De-La-Maria</surname> <given-names>C.</given-names></name> <name><surname>Faull</surname> <given-names>K.</given-names></name> <name><surname>Yoon</surname> <given-names>A.</given-names></name> <etal/></person-group>. (<year>2017</year>). <article-title>Perturbations of phosphatidate cytidylyltransferase (CdsA) mediate daptomycin resistance in <italic>Streptococcus mitis/oralis</italic> by a novel mechanism</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>61</volume>, <fpage>1</fpage>&#x2013;<lpage>13</lpage>. doi: <pub-id pub-id-type="doi">10.1128/AAC.02435-16</pub-id>, PMID: <pub-id pub-id-type="pmid">28115347</pub-id></citation></ref>
<ref id="ref44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mistry</surname> <given-names>J.</given-names></name> <name><surname>Chuguransky</surname> <given-names>S.</given-names></name> <name><surname>Williams</surname> <given-names>L.</given-names></name> <name><surname>Qureshi</surname> <given-names>M.</given-names></name> <name><surname>Salazar</surname> <given-names>G. A.</given-names></name> <name><surname>Sonnhammer</surname> <given-names>E. L. L.</given-names></name> <etal/></person-group>. (<year>2021</year>). <article-title>Pfam: The protein families database in 2021</article-title>. <source>Nucleic Acids Res.</source> <volume>49</volume>, <fpage>D412</fpage>&#x2013;<lpage>D419</lpage>. doi: <pub-id pub-id-type="doi">10.1093/nar/gkaa913</pub-id>, PMID: <pub-id pub-id-type="pmid">33125078</pub-id></citation></ref>
<ref id="ref45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mukhopadhyay</surname> <given-names>K.</given-names></name> <name><surname>Whitmire</surname> <given-names>W.</given-names></name> <name><surname>Xiong</surname> <given-names>Y. O.</given-names></name> <name><surname>Molden</surname> <given-names>J.</given-names></name> <name><surname>Jones</surname> <given-names>T.</given-names></name> <name><surname>Peschel</surname> <given-names>A.</given-names></name> <etal/></person-group>. (<year>2007</year>). <article-title><italic>In vitro</italic> susceptibility of <italic>Staphylococcus aureus</italic> to thrombin-induced platelet microbicidal protein-1 (tPMP-1) is influenced by cell membrene phospholipid composition and asymmetry</article-title>. <source>Microbiology</source> <volume>153</volume>, <fpage>1187</fpage>&#x2013;<lpage>1197</lpage>. doi: <pub-id pub-id-type="doi">10.1099/mic.0.2006/003111-0</pub-id>, PMID: <pub-id pub-id-type="pmid">17379728</pub-id></citation></ref>
<ref id="ref46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Munoz-Price</surname> <given-names>L. S.</given-names></name> <name><surname>Lolans</surname> <given-names>K.</given-names></name> <name><surname>Quinn</surname> <given-names>J. P.</given-names></name></person-group> (<year>2005</year>). <article-title>Emergence of resistance to daptomycin during treatment of vancomycin-resistant <italic>Enterococcus faecalis</italic> infection</article-title>. <source>Clin. Infect. Dis.</source> <volume>41</volume>, <fpage>565</fpage>&#x2013;<lpage>566</lpage>. doi: <pub-id pub-id-type="doi">10.1086/432121</pub-id>, PMID: <pub-id pub-id-type="pmid">16028170</pub-id></citation></ref>
<ref id="ref47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Prater</surname> <given-names>A. G.</given-names></name> <name><surname>Mehta</surname> <given-names>H. H.</given-names></name> <name><surname>Beabout</surname> <given-names>K.</given-names></name> <name><surname>Supandy</surname> <given-names>A.</given-names></name> <name><surname>Miller</surname> <given-names>W. R.</given-names></name> <name><surname>Tran</surname> <given-names>T. T.</given-names></name> <etal/></person-group>. (<year>2021</year>). <article-title>Daptomycin resistance in <italic>Enterococcus faecium</italic> can be delayed by disruption of the LiaFSR stress response pathway</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>65</volume>, <fpage>1</fpage>&#x2013;<lpage>6</lpage>. doi: <pub-id pub-id-type="doi">10.1128/AAC.01317-20</pub-id>, PMID: <pub-id pub-id-type="pmid">33468468</pub-id></citation></ref>
<ref id="ref48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Prater</surname> <given-names>A. G.</given-names></name> <name><surname>Mehta</surname> <given-names>H. H.</given-names></name> <name><surname>Kosgei</surname> <given-names>A. J.</given-names></name> <name><surname>Miller</surname> <given-names>W. R.</given-names></name> <name><surname>Tran</surname> <given-names>T. T.</given-names></name> <name><surname>Arias</surname> <given-names>C. A.</given-names></name> <etal/></person-group>. (<year>2019</year>). <article-title>Environment shapes the accessible daptomycin resistance mechanisms in <italic>Enterococcus faecium</italic></article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>63</volume>, <fpage>3</fpage>&#x2013;<lpage>5</lpage>. doi: <pub-id pub-id-type="doi">10.1128/AAC.00790-19</pub-id>, PMID: <pub-id pub-id-type="pmid">31332078</pub-id></citation></ref>
<ref id="ref49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Punta</surname> <given-names>M.</given-names></name> <name><surname>Coggill</surname> <given-names>P. C.</given-names></name> <name><surname>Eberhardt</surname> <given-names>R. Y.</given-names></name> <name><surname>Mistry</surname> <given-names>J.</given-names></name> <name><surname>Tate</surname> <given-names>J.</given-names></name> <name><surname>Boursnell</surname> <given-names>C.</given-names></name> <etal/></person-group>. (<year>2011</year>). <article-title>The Pfam protein families database</article-title>. <source>Nucleic Acids Res.</source> <volume>32</volume>, <fpage>138D</fpage>&#x2013;<lpage>1141D</lpage>. doi: <pub-id pub-id-type="doi">10.1093/nar/gkh121</pub-id>, PMID: <pub-id pub-id-type="pmid">14681378</pub-id></citation></ref>
<ref id="ref50"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Qian</surname> <given-names>Y.</given-names></name> <name><surname>Zhao</surname> <given-names>X.</given-names></name></person-group> (<year>2014</year>). <article-title>A comparison of methods for the extraction of bacterial genomic DNA in rat feces</article-title>. <source>Sci. Technol. Food Ind.</source> <volume>35</volume>, <fpage>166</fpage>&#x2013;<lpage>169</lpage>. doi: <pub-id pub-id-type="doi">10.13386/j.issn1002-0306.2014.04.005</pub-id></citation></ref>
<ref id="ref51"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ren</surname> <given-names>J.</given-names></name> <name><surname>Wen</surname> <given-names>L.</given-names></name> <name><surname>Gao</surname> <given-names>X.</given-names></name> <name><surname>Jin</surname> <given-names>C.</given-names></name> <name><surname>Xue</surname> <given-names>Y.</given-names></name> <name><surname>Yao</surname> <given-names>X.</given-names></name></person-group> (<year>2009</year>). <article-title>DOG 1.0: illustrator of protein domain structures</article-title>. <source>Cell Res.</source> <volume>19</volume>, <fpage>271</fpage>&#x2013;<lpage>273</lpage>. doi: <pub-id pub-id-type="doi">10.1038/cr.2009.6</pub-id>, PMID: <pub-id pub-id-type="pmid">19153597</pub-id></citation></ref>
<ref id="ref52"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saier</surname> <given-names>M. H.</given-names> <suffix>Jr.</suffix></name> <name><surname>Reddy</surname> <given-names>V. S.</given-names></name> <name><surname>Tamang</surname> <given-names>D. G.</given-names></name> <name><surname>V&#x00E4;stermark</surname> <given-names>&#x00C5;.</given-names></name></person-group> (<year>2013</year>). <article-title>The transporter classification database</article-title>. <source>Nucleic Acids Res.</source> <volume>42</volume>, <fpage>D251</fpage>&#x2013;<lpage>D258</lpage>. doi: <pub-id pub-id-type="doi">10.1093/nar/gkt1097</pub-id>, PMID: <pub-id pub-id-type="pmid">24225317</pub-id></citation></ref>
<ref id="ref53"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schwarz</surname> <given-names>F. V.</given-names></name> <name><surname>Perreten</surname> <given-names>V.</given-names></name> <name><surname>Teuber</surname> <given-names>M.</given-names></name></person-group> (<year>2001</year>). <article-title>Sequence of the 50-kb conjugative multiresistance plasmid pRE25 from <italic>Enterococcus faecalis</italic> RE25</article-title>. <source>Plasmid</source> <volume>46</volume>, <fpage>170</fpage>&#x2013;<lpage>187</lpage>. doi: <pub-id pub-id-type="doi">10.1006/plas.2001.1544</pub-id>, PMID: <pub-id pub-id-type="pmid">11735367</pub-id></citation></ref>
<ref id="ref54"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sletvold</surname> <given-names>H.</given-names></name> <name><surname>Johnsen</surname> <given-names>P. J.</given-names></name> <name><surname>Simonsen</surname> <given-names>G. S.</given-names></name> <name><surname>Aasn&#x00E6;s</surname> <given-names>B.</given-names></name> <name><surname>Sundsfjord</surname> <given-names>A.</given-names></name> <name><surname>Nielsen</surname> <given-names>K. M.</given-names></name></person-group> (<year>2007</year>). <article-title>Comparative DNA analysis of two <italic>vanA</italic> plasmids from <italic>Enterococcus faecium</italic> strains isolated from poultry and a poultry farmer in Norway</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>51</volume>, <fpage>736</fpage>&#x2013;<lpage>739</lpage>. doi: <pub-id pub-id-type="doi">10.1128/AAC.00557-06</pub-id>, PMID: <pub-id pub-id-type="pmid">17116680</pub-id></citation></ref>
<ref id="ref55"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Suleyman</surname> <given-names>G.</given-names></name> <name><surname>Mahan</surname> <given-names>M.</given-names></name> <name><surname>Zervos</surname> <given-names>M. J.</given-names></name></person-group> (<year>2017</year>). <article-title>Comparison of daptomycin and linezolid in the treatment of vancomycin-resistant <italic>Enterococcus faecium</italic> in the absence of endocarditis</article-title>. <source>Infect. Dis. Clin. Pract.</source> <volume>25</volume>, <fpage>151</fpage>&#x2013;<lpage>154</lpage>. doi: <pub-id pub-id-type="doi">10.1097/IPC.0000000000000482</pub-id></citation></ref>
<ref id="ref56"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname> <given-names>H. L.</given-names></name> <name><surname>Liu</surname> <given-names>C.</given-names></name> <name><surname>Zhang</surname> <given-names>J. J.</given-names></name> <name><surname>Zhou</surname> <given-names>Y. M.</given-names></name> <name><surname>Xu</surname> <given-names>Y. C.</given-names></name></person-group> (<year>2019a</year>). <article-title>Molecular characterization of vancomycin-resistant enterococci isolated from a hospital in Beijing, China</article-title>. <source>J. Microbiol. Immunol. Infect.</source> <volume>52</volume>, <fpage>433</fpage>&#x2013;<lpage>442</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jmii.2018.12.008</pub-id>, PMID: <pub-id pub-id-type="pmid">30827858</pub-id></citation></ref>
<ref id="ref57"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname> <given-names>L.</given-names></name> <name><surname>Qu</surname> <given-names>T.</given-names></name> <name><surname>Wang</surname> <given-names>D.</given-names></name> <name><surname>Chen</surname> <given-names>Y.</given-names></name> <name><surname>Fu</surname> <given-names>Y.</given-names></name> <name><surname>Yang</surname> <given-names>Q.</given-names></name> <etal/></person-group>. (<year>2019b</year>). <article-title>Characterization of <italic>vanM</italic> carrying clinical <italic>Enterococcus</italic> isolates and diversity of the suppressed <italic>vanM</italic> gene cluster</article-title>. <source>Infect. Genet. Evol.</source> <volume>68</volume>, <fpage>145</fpage>&#x2013;<lpage>152</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.meegid.2018.12.015</pub-id>, PMID: <pub-id pub-id-type="pmid">30553064</pub-id></citation></ref>
<ref id="ref58"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname> <given-names>L.</given-names></name> <name><surname>Xu</surname> <given-names>J.</given-names></name> <name><surname>Wang</surname> <given-names>W.</given-names></name> <name><surname>He</surname> <given-names>F.</given-names></name></person-group> (<year>2020</year>). <article-title>Emergence of <italic>vanA</italic>-type vancomycin-resistant <italic>Enterococcus faecium</italic> ST 78 strain with a rep2-type plasmid carrying a Tn1546-like element isolated from a urinary tract infection in China</article-title>. <source>Infect. Drug Resist.</source> <volume>13</volume>, <fpage>949</fpage>&#x2013;<lpage>955</lpage>. doi: <pub-id pub-id-type="doi">10.2147/IDR.S247569</pub-id>, PMID: <pub-id pub-id-type="pmid">32308438</pub-id></citation></ref>
<ref id="ref59"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tannert</surname> <given-names>A.</given-names></name> <name><surname>Pohl</surname> <given-names>A.</given-names></name> <name><surname>Pomorski</surname> <given-names>T.</given-names></name> <name><surname>Herrmann</surname> <given-names>A.</given-names></name></person-group> (<year>2003</year>). <article-title>Protein-mediated transbilayer movement of lipids in eukaryotes and prokaryotes: the relevance of ABC transporters</article-title>. <source>Int. J. Antimicrob. Agents</source> <volume>22</volume>, <fpage>177</fpage>&#x2013;<lpage>187</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0924-8579(03)00217-6</pub-id>, PMID: <pub-id pub-id-type="pmid">13678819</pub-id></citation></ref>
<ref id="ref60"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tran</surname> <given-names>T. T.</given-names></name> <name><surname>Munita</surname> <given-names>J. M.</given-names></name> <name><surname>Arias</surname> <given-names>C. A.</given-names></name></person-group> (<year>2015</year>). <article-title>Mechanisms of drug resistance: daptomycin resistance</article-title>. <source>Ann. N. Y. Acad. Sci.</source> <volume>1354</volume>, <fpage>32</fpage>&#x2013;<lpage>53</lpage>. doi: <pub-id pub-id-type="doi">10.1111/nyas.12948</pub-id>, PMID: <pub-id pub-id-type="pmid">26495887</pub-id></citation></ref>
<ref id="ref61"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tran</surname> <given-names>T. T.</given-names></name> <name><surname>Panesso</surname> <given-names>D.</given-names></name> <name><surname>Gao</surname> <given-names>H.</given-names></name> <name><surname>Roh</surname> <given-names>J. H.</given-names></name> <name><surname>Munita</surname> <given-names>J. M.</given-names></name> <name><surname>Reyes</surname> <given-names>J.</given-names></name> <etal/></person-group>. (<year>2013a</year>). <article-title>Whole-genome analysis of a daptomycin-susceptible <italic>Enterococcus faecium</italic> strain and its daptomycin-resistant variant arising during therapy</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>57</volume>, <fpage>261</fpage>&#x2013;<lpage>268</lpage>. doi: <pub-id pub-id-type="doi">10.1128/AAC.01454-12</pub-id>, PMID: <pub-id pub-id-type="pmid">23114757</pub-id></citation></ref>
<ref id="ref62"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tran</surname> <given-names>T. T.</given-names></name> <name><surname>Panesso</surname> <given-names>D.</given-names></name> <name><surname>Mishra</surname> <given-names>N. N.</given-names></name> <name><surname>Mileykovskaya</surname> <given-names>E.</given-names></name> <name><surname>Guan</surname> <given-names>Z.</given-names></name> <name><surname>Munita</surname> <given-names>J. M.</given-names></name> <etal/></person-group>. (<year>2013b</year>). <article-title>Daptomycin-resistant <italic>Enterococcus faecalis</italic> diverts the antibiotic molecule from the division septum and remodels cell membrane phospholipids</article-title>. <source>MBio</source> <volume>4</volume>:<fpage>e00281-13</fpage>. doi: <pub-id pub-id-type="doi">10.1128/mBio.00281-13</pub-id>, PMID: <pub-id pub-id-type="pmid">23882013</pub-id></citation></ref>
<ref id="ref63"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Uttley</surname> <given-names>A. C.</given-names></name> <name><surname>Collins</surname> <given-names>C. H.</given-names></name> <name><surname>Naidoo</surname> <given-names>J.</given-names></name> <name><surname>George</surname> <given-names>R. C.</given-names></name></person-group> (<year>1988</year>). <article-title>Vancomycin-resistant enterococci</article-title>. <source>Lancet</source> <volume>331</volume>, <fpage>57</fpage>&#x2013;<lpage>58</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0140-6736(88)91037-9</pub-id></citation></ref>
<ref id="ref64"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vading</surname> <given-names>M.</given-names></name> <name><surname>Samuelsen</surname> <given-names>H. B.</given-names></name> <name><surname>Sundsfjord</surname> <given-names>A. S.</given-names></name> <name><surname>Giske</surname> <given-names>C. G.</given-names></name></person-group> (<year>2011</year>). <article-title>Comparison of disk diffusion, Etest and VITEK2 for detection of carbapenemase-producing <italic>Klebsiella pneumoniae</italic> with the EUCAST and CLSI breakpoint systems</article-title>. <source>Clin. Microbiol. Infect.</source> <volume>17</volume>, <fpage>668</fpage>&#x2013;<lpage>674</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1469-0691.2010.03299.x</pub-id>, PMID: <pub-id pub-id-type="pmid">20649801</pub-id></citation></ref>
<ref id="ref65"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>T. H.</given-names></name> <name><surname>Muraih</surname> <given-names>J. K.</given-names></name> <name><surname>Tishbi</surname> <given-names>N.</given-names></name> <name><surname>Herskowitz</surname> <given-names>J.</given-names></name> <name><surname>Victor</surname> <given-names>R. L.</given-names></name> <name><surname>Silverman</surname> <given-names>J.</given-names></name> <etal/></person-group>. (<year>2014</year>). <article-title>Cardiolipin prevents membrane translocation and permeabilization by daptomycin</article-title>. <source>J. Biol. Chem.</source> <volume>289</volume>, <fpage>11584</fpage>&#x2013;<lpage>11591</lpage>. doi: <pub-id pub-id-type="doi">10.1074/jbc.M114.554444</pub-id>, PMID: <pub-id pub-id-type="pmid">24616102</pub-id></citation></ref>
<ref id="ref66"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname> <given-names>Y.</given-names></name> <name><surname>Liang</surname> <given-names>Y.</given-names></name> <name><surname>Lynch</surname> <given-names>K. H.</given-names></name> <name><surname>Dennis</surname> <given-names>J. J.</given-names></name> <name><surname>Wishart</surname> <given-names>D. S.</given-names></name></person-group> (<year>2011</year>). <article-title>PHAST: A fast phage search tool</article-title>. <source>Nucleic Acids Res.</source> <volume>39</volume>, <fpage>W347</fpage>&#x2013;<lpage>W352</lpage>. doi: <pub-id pub-id-type="doi">10.1093/nar/gkr485</pub-id>, PMID: <pub-id pub-id-type="pmid">21672955</pub-id></citation></ref>
</ref-list>
<fn-group>
<fn id="fn0004">
<p><sup>1</sup><ext-link xlink:href="https://cge.food.dtu.dk/services/MLST/" ext-link-type="uri">https://cge.food.dtu.dk/services/MLST/</ext-link></p>
</fn>
<fn id="fn0005">
<p><sup>2</sup><ext-link xlink:href="https://cge.food.dtu.dk/services/PlasmidFinder/" ext-link-type="uri">https://cge.food.dtu.dk/services/PlasmidFinder/</ext-link></p>
</fn>
</fn-group>
</back>
</article>